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Trans-Acting Factors Affecting Retroviral Recoding
Lisa Green
 The production of retroviral enzymes requires a translational recoding event which 
subverts normal decoding, either by direct suppression of termination with the insertion of an 
amino acid at a stop codon (readthrough), or by an alteration of the reading frame of the mRNA 
(frameshift). It has been determined that retroviral readthrough and frameshift require cis-acting 
factors in the mRNA to stimulate recoding on the eukaryotic ribosome. Here we investigate the 
affects of trans-acting factors on recoding, primarily in the context of the MoMLV gag-pol 
junction. 
  We report the effects of a host  protein, Large Ribosomal Protein Four (RPL4), on the 
efficiency of recoding. Using a dual luciferase reporter assay, we show that transfection of cells 
with an RPL4 cDNA expression construct  enhances recoding efficiency in a dose-dependent 
manner. The increase in the frequency of recoding can be more than 2-fold, adequate to disrupt 
normal viral production. This effect is cell line specific, and appears to be distinct to RPL4 
among ribosomal proteins.
 The RPL4 increase occurs with both retroviral readthrough and frameshift sequences, and 
even at other viral readthrough regions that do not involve RNA secondary structures.  We show 
that RPL4 effects are negated by release factor over-expression, and that RPL4 will increase 
readthrough above the levels of a hyperactive mutant and in addition to G418. When co-
transfected with Moloney murine leukemia provirus, the RPL4-mediated increase in readthrough 
reduces the amount of virus released. 
 We also examined the effects of aminoglycoside drugs and the small molecule PTC124 
on readthrough of the MoMLV gag-pol junction. We show that G418, paromomycin and PTC124 
increase readthrough of our MoMLV reporter in a dose dependent manner in 293A cells. These 
drugs reduce viral replication, as measured by a recombinant transducing virus assay. We further 
examine G418 and paromomycin in an in-vitro system; readthrough is increased to higher levels 
than those seen in vivo. G418 displays deleterious effects on cell viability and overall translation. 
Paromomycin does not appear as toxic, suggesting differences in interactions by which these 
drugs enhance readthrough. 
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Chapter 1: Introduction
Viruses are extraordinary bio-machines – parasitic entities assembled from biological 
components that are programmed to replicate.  Efficient and compact, viral particles 
contain distinct genes and unique proteins that enable them to exploit the natural 
functions of higher organisms to produce more virus. A viral particle must  utilize host 
cells’ innate functions in order to replicate and resultant pathology  in the host is 
ultimately  a means to ensure viral spread. Viruses are truly fascinating as they exist at the 
edge of life – they are not  free-living themselves, but are bound by the dictates of 
biological organisms, and depend on the life processes of the cells they infect to exist. 
Natural selection has put evolutionary pressure on the virus, and those particles that 
escape destruction by the host and maximize their replication are successful and survive. 
Multiple viral genes and gene products inactivate facets of the immune system, and 
‘exploit normal cellular processes’ to enable production of progeny virus. Perhaps most 
ubiquitous of this ‘borrowing’ of host services is the use of the host cell’s translational 
machinery  to produce viral proteins. Ribosomes, tRNAs, elongation and termination 
factors are provided by the host cells. Many viruses have developed processes that 
capitalize on normal translational functions, and also abnormal functions, to allow 
production of viral proteins in a preferential or specific manner. The phenomenon of 
recoding – alternate interpretation of mRNAs on the ribosome during translation — is 
used by many viruses, and is the subject of this dissertation. 
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Retroviruses
A particular class of viruses that utilize recoding in production of their proteins is also 
unique in its type of infection. Retroviruses are enveloped viruses that bud from the host 
cells and carry their genome as two copies of a single RNA sequence (Figure 1-1). The 
viral genome is reverse transcribed into double-stranded DNA and stably  incorporated 
into the genome of the host as a provirus, thereby establishing a permanent and 
potentially heritable infection. Thus the infected host is never free of the infection; the 
virus may lie dormant for a variety of reasons, but  the integration of the viral genome is 
permanent and constitutes a mutation. 
Many organisms contain endogenous retro-elements — archived sequences from 
previous viral infections. In humans, endogenous retroviruses (HERVs) have been 
implicated in autoimmune syndromes such as rheumatoid arthritis; patients test  positive 
for HTLV antigens which are cross-reactive with proteins in afflicted tissues, but do not 
have antibodies against the virus, indicating expression of an incomplete viral sequence 
(Balada, Vilardell-Tarres et al. 2010). Active infection by retroviruses is endemic to some 
species, and can combine with endogenous retro-elements. Combination of exo- and 
endogenous retroviral sequences can cause pathology and a high incidence of lethality. 
The majority of mice, for example, carry a murine leukemia virus, while a substantial 
percentage of cats are infected by feline leukemia virus.  However retro-elements are 
predominately innocuous, and some may even have acquired a positive role in the host 
2
3Figure 1-1. Viral Particles. (A) An example of immature and mature 
gammaretrovius, i.e. MoMLV. (B) An example of immature and mature lentivirus, 
HIV-1. HIV-1 has a distinctive truncated cone shaped core upon maturation 
(ViralZone:www.expasy.org/viralzone, Swiss Institute of Bioinformatics.)
© ViralZone 2010, Swiss Institute of Bioinformatics
A
B
physiology. In mice and humans, endogenous retro-elements appear to have a role in 
differentiation of early embryonic tissues in development (Jern and Coffin 2008) 
(Macfarlan, Gifford et al. 2011). 
Retroviruses were originally grouped by morphology, but now are classified into seven 
genera, based on similarities in nucleotide sequence (Table 1). The events of the retroviral 
replication cycle (Figure 2) are conventionally  divided into two categories separated by 
the completion of the integration of viral DNA: the early events, which include infection 
through to integration of the provirus, and the late events, starting with transcription of 
the retroviral genes from the integrated provirus and concluding with the release and 
subsequent maturation of the nascent virions. A single retroviral particle contains two 
copies of single-stranded RNA, approximately  8.5 kb in length, which contain all the 
genes of the virus. All retroviruses share the basic simple genome organization with 
genes encoding the same proteins: structural proteins (capsid, matrix, nucleocapsid) from 
the gag gene, replication enzymes from pol gene, and surface proteins that mediate entry 
and fusion from the env gene. After transcription from the proviral DNA, full-length 
mRNAs act as both templates for translation of gag and pol genes and as genomes for 
packaging into new virions (Figure 1-3). Env proteins are translated from a spliced 
mRNA, and complex retroviruses produce a variety of additional proteins through 
multiple splicing events. These accessory proteins can promote infection by thwarting 
various aspects of the immune system, or otherwise aid in retroviral replication 
(Kirchhoff 2010). 
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Table 1-1: Classification of retroviruses and related spumavirus. Genera is 
based on sequence similarities in the pol gene. Morphology is divided into types 
based on surface and core.
6Adsorption to specific receptor
Membrane fusion and endocytosis




Transport of dsDNA to nucleus
Integration of viral DNA 
Generation of provirus 
Transcription
Splicing






Export of genomic RNA and mRNA
 
 
Figure 1-2: Retroviral replication cycle. Early events begin with adsorption and 
culminate at integration  of viral DNA. Late events include transcription to maturation. 
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Figure 1-3. Simple and complex retroviral genome. (A) MoMLV genome consisting 
of gag, pro/pol and env genes. (B) HIV-1 genome with gag, pro/pol and env plus 
accessory genes produced by splicing events (ViralZone:www.expasy.org/viralzone, 
Swiss Institute of Bioinformatics.)
© ViralZone 2010, Swiss Institute of Bioinformatics
A 
B 
The early  phase of the retroviral life cycle begins with recognition of receptor on the 
outside of a host cell by virally-encoded envelope proteins that stud the surface of the 
virion.  The initial interaction between the virion and host cell may be non-specific, but 
the interaction between cellular receptor and viral surface (SU) proteins result in 
stabilization of the two that allows entry of the virion into the host cell.
Entry  of the viral components into the host cell occurs via fusion of viral and cellular 
membranes mediated by  a conformational change in viral transmembrane proteins that 
pull the lipids membranes of the cell and virion together. Conventionally it  has been 
understood that fusion occurs at the cell surface. However, some viruses such as MLV 
enter via a pH-dependent pathway, presumably  involving acidification in the endosome. 
Furthermore, recently it has been demonstrated that HIV may sometimes enter cells 
through an endosomic pathway (Miyauchi, Kim et al. 2009; Miyauchi, Marin et al. 2011) 
or even via a viral/immunological synapse between cells (Haller and Fackler 2008). 
After viral attachment and entry, uncoating occurs. The viral genome and virally  encoded 
enzymes are separated from the lipid bilayer of the virus stripped, to some extent, of the 
structural proteins matrix and capsid. The RNA genome is then converted to proviral 
DNA by the viral reverse transcriptase enzyme. This process requires a cellular tRNA 
bound to the viral RNA to function as a primer; the specific tRNA chosen to serve as 
8
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Figure 1-4. Reverse Transcription. DNA synthesis begins with (-) strand DNA 
initiated at the primer binding site (PBS) with a cellular tRNA. The retroviral reverse 
transcriptase enzyme (RT), which is both a DNA polymerase and an RNA nuclease,  
creates a short DNA segment  the minus strand strong stop  (-sssDNA). The R sequence 
of the  -sssDNA anneals to the R sequence at the 3’ end of the RNA (first strand 
transfer).  -sssDNA acts as the primer for the rest of minus strand DNA. RT degrades 
the RNA template as DNA is polymerized, except for the PPT, which primes 
transcription of the first portion of plus strand DNA at 3’ end of the minus strand DNA. 
This produces another short fragment of DNA, the plus strand strong stop (+sssDNA).  
RT degrades the PPT RNA after the +sssDNA has been primed, and the +sssDNA is 
transcribed using the  -sssDNA and the tRNA primer as a template, allowing 
reconstitution of the PBS on the plus strand DNA. The minus and plus strands are 
annealed (second strand transfer) through the PBS sequences, and circularization of the 
minus strand DNA allows transcription of the remainder of the plus strand DNA. 
5’ 3’AAA
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primer varies with the retrovirus (MoMLV requires tRNApro and HIV, tRNALys3). Reverse 
transcription produces a double-stranded DNA molecule that is not  identical to the viral 
RNA; the process of transcription generates  5’ and 3’ terminal sequences that serve as 
regulatory sequences for the DNA provirus once it is integrated (Figure 1-4). The reverse 
transcription reaction is also notable because it  allows genetic recombination. Because 
the virion carries two copies of the genome, it can harbor genomes of two separate 
retroviruses that have infected the cell. Cross-over during transcription allows swapping 
of sequences, much like inter-strand exchange during mitosis.  Deficient sequences can 
complement each other to produce infectious and/or pathological virus, as described in 
the case of endogenous retroelements.
When reverse transcription is complete, the double stranded DNA provirus enters the 
nucleus. This process is also different among retroviruses: some, such as MoMLV, require 
that the cell undergo division so there is a breakdown of the nuclear lamina. HIV 
however can infect non-dividing cells. Entry into the nucleus is a function of the pre-
integration complex (PIC) containing the provirus, viral integrase, and perhaps cellular 
chaperones. The exact identity of the components of the PIC is unknown at this time, 
although some mediators of nuclear entry  have been tentatively identified. After entry 
into the nucleus, the provirus is inserted into the host genome via the viral integrase. 
Insertion site preferences also vary according to retrovirus; gammaretroviruses integrate 
into transcription start sites, lentiviruses tend to integrate non-preferentially  into all 
regions of active transcription, and deltaretroviruses display  no trends in integration sites 
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(reviewed in (Ciuffi 2008). Insertion next to genes that control the cell life cycle can 
cause cancer due to the active promoter of the retrovirus. Transcription of viral mRNA is 
mediated by the LTR, and the RNA is 5’ capped and poly-adenylated, and exported to the 
cytoplasm.
Once in the cytoplasm, viral mRNA is translated by  the host ribosomes. During the 
replication of retroviruses translation of the pol genes is dependent  on translation of the 
upstream gag proteins; pol lacks a start codon and is only translated as a fusion protein 
with the upstream gag protein. This process requires a recoding event to subvert the 
normal termination that occurs at the end of gag with an efficiency of about 5%, and is 
explored in the work described in this thesis. The env proteins are translated from a 
spliced mRNA and are cleaved by both viral and cellular proteases (Coffin 1997). Gag, 
gag-pol and env proteins are transported to the cell membrane where they assemble. The 
Psi (ψ) packaging signal in the 5’ non-coding region of the mRNA mediates the 
association between the RNA genome and the structural components of the core. The 
stoichiometry of viral components is critical for proper assembly and RNA genome 
recruitment; proper regulation of the ratio of translation of gag and gag-pol products is a 
necessary  factor in viral replication. After assembly, nascent virions bud from the plasma 
membrane. The virus matures only after release from the cell; the viral protease cleaves 
the precursor gag and gag-pol to allow the mature core to form. 
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Viral infections can cause pathogenesis as virions replicate and disseminate. Many 
viruses kill their host cells through lytic release of progeny, and cause disease to the 
organism as a whole by specific disregulation of immune response and disruption of 
normal function. In retroviral infections, release of virus occurs continuously  over the life 
of the cell as most retroviruses generally do not cause lysis or cell death through their 
replication cycle. In many organisms, the ability of the retrovirus to integrate into the 
genome and disrupt the normal sequence of DNA causes disease in the host, not the 
actual production of virus. The discovery and study  of retroviruses lead to the 
understanding of cancer as a result  of genetic lesions.  Discovery of cancer-causing 
infectious agents, the avian sarcoma/leukosis viruses in the early 1900s, lead to 
understanding that  cancer was a genetic —DNA encoded— disease, and to the eventual 
establishment of the field of molecular biology. Later, in the 1980s, HTLV and HIV were 
identified as the first known retroviruses to infect humans and cause pathology.
Through integration retroviruses are able to disrupt normal cellular growth regulation and 
affect proliferation, causing oncogenesis. Retroviruses may also acquire a portion of a 
gene in the process of integration. The cellular gene becomes part of the genome of 
progeny virus, and is transmitted to newly infective cells. If the cellular gene has 
oncogenic potential, the virus can become acutely transforming. Studies of Abelson 
Mouse Murine Leukemia virus lead to the identification of the gene v-Abl, which is 
carried by the virus and upon integration, causes leukemia in mice. In the 1980s it was 
discovered that the viral gene had a cellular homolog (Goff, Gilboa et al. 1980) (Davis, 
12
Konopka et al. 1985), and c-Abl was cloned, which allowed further study. It was revealed 
that a single cellular event, a chromosome break and translocation, resulted in the 
causative agent for chronic myologenous leukemia in humans, (Shtivelman, Lifshitz et al. 
1985), (Ben-Neriah, Daley et al. 1986) . The Philadelphia chromosome, as this product  of 
this recombination is called, is the fusion of the Abl promoter and the BCR tyrosine 
kinase, a pro-growth regulatory gene, which results in a powerful recombinant oncogene. 
This recombination is not unlike a scenario of retroviral infection in its ultimate result; 
the linear sequence of the host DNA is changed permanently, and the regulation that 
depends on proximity of adjacent sequences is lost. Thus, as a genetic mutation, infection 
with a retrovirus leaves an indelible mark on the host; the provirus, providing the 
blueprint of the virus, remains for as long as the cell it infected lives and divides. 
Due to permanent presence of the retrovirus, those that cause pathology result  in 
omnipresent danger to the host. In addition, initial infection is often silent and non-
symptomatic, with disease developing only  after the virus has established a widespread 
infection in the host. After integration, viral genes are transcribed and translated using the 
host cell machinery. Just as the study of transforming retroviruses lead to understanding 
of cellular causes of oncogenesis, investigation of translation of viral proteins is a tool for 
understanding normal regulation of protein synthesis.
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Figure 1-5: General structure and organization of the ribosome. Cyrogenic 
electron microscope map of the 70S (prokayrotic) ribosome, the 30S subunit and 
the 50S subunit. The P- and A- site are depicted in green and magenta 
respectively. The position of the decoding center (DC) active site the GTPase 
associated center (GAC) and the peptidyltransferase center (PTC) are also  















Translation of proteins is a complex and highly regulated process.  The ribosome has 
evolved to interpret the genetic code (via messenger RNA) and produce proteins, which 
perform the majority of functions of the cell. Multiple additional factors regulate 
ribosome biogenesis, initiation, elongation and termination steps the translation, and 
ribosome recycling. Translational processes take up  the majority  of the ‘life’ of the cell, 
both in energy  resources and gene products, thus highlighting the importance and 
intricacy of the translation machinery. 
The ribosome is a composite macromolecule of proteins and RNA segments which reads 
messenger RNA and conducts assembly of amino acids into proteins.  The ribosome is a 
physical arena for production of proteins, and is responsible for selection of the correct 
amino acid in the correct order and for promoting the linkage of amino acids through 
creation of the peptide bond. In all organisms, the ribosome consists of two subunits, 
small and large, and multiple separate RNA segments. The completed prokaryotic 
ribosome consists of 3 rRNA segments and 57 proteins, with a combined sedimentation 
value of 70S. Individually, the 30S subunit contains the 16S rRNA, and 23 proteins, and 
the 50s subunit contains 5S and 23S rRNA and 34 proteins. The eukaryotic ribosome is 
larger, and the whole ensemble is measured at 80S; the 40S subunit contains a longer 18s 
rRNA and 33 proteins, the 60S subunit has 5S and 28S rRNAs, plus the eukaryotic 
specific 5.8S rRNA, and 46 proteins. The small subunit houses the decoding center, 
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Table 1-2. Conservation of Ribosomal Proteins across kingdoms. Lecompte et al, 
Comparative analysis of ribosomal proteins in complete genomes: and example of 
reductive evolution at the domain scale, Nucleic Acids Research, 2002, Vol. 30, Issue 
24, p. 5384  by permission of Oxford University Press. (Lecompte, Ripp et al. 2002)
where the coding sequence dictated by mRNA is translated into the corresponding 
peptide, and the large subunit contains the peptidyl transferase center (PTC) where the 
acceptor arm of the tRNA is accommodated and peptide bonds are formed (Figure 1-5). 
The ribosomal subunits move in relation to each other in a motion termed ratcheting to 
advance the tRNA and mRNA through the active site of translation.     
In all ribosomes, the processes of proofreading and peptide bond formation are mediated 
by the rRNA. Initiation and termination events are carried out by extra-ribosomal 
proteins which are not homologous among kingdoms, although there is homology among 
the elongation factors. Alignment of prokaryotic and eukaryotic ribosomal protein 
sequences and comparison of their predicted structures have lead to a designation of 
some proteins being considered conserved among all organism, while others are unique to 
one or a subset of kingdoms (Table 1-2) (Lecompte, Ripp et al. 2002). Homologous 
regions of rRNA between kingdoms have also suggested that the reactions mediated by 
rRNA work by universal mechanisms. 
Ribosomes can accommodate three tRNAs at  a time; each tRNA moves through the A, P 
and E sites sequentially as the tRNA is accepted as a cognate match to the mRNA codon 
and peptide bond formation occurs. An amino-acylated tRNA enters the ribosome at the 
A (amino-acyl) site, after the match between the codon of the mRNA and the anticodon 
of the tRNA are verified in the decoding center. This assures that the amino acid carried 
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by the tRNA is the one specified by  the mRNA. Next, peptide bond formation occurs 
between the amino acid on the tRNA in the adjacent P (peptidyl) site, with the newly 
added amino acid at the C terminal end of the nascent peptide. The tRNA in the A site, 
now attached to the nascent peptide, moves to the P site, and the empty tRNA in the P site 
moves to the last site, the E (exit) site (Figure 1-6). 
Most of the understanding of the basic mechanisms of translation elongation and 
termination comes from study of prokaryotic organisms. Structural information was 
obtained primarily from bacterial ribosome; the structure of an E. coli 70S ribosome was 
obtained in 1998 (Malhotra, Penczek et al. 1998) through cryo-electron microscopy. The 
ease of manipulation of genetics in single-cell organisms has allowed for mutational 
studies of conserved regions of rRNA and proteins. Reconstitution of bacterial 
translational systems has enabled mechanistic studies into functions of initiation, 
elongation and termination factors.  The intersection of crystallography and cryo-EM has 
allowed reconstruction of eukaryotic ribosomes (Taylor, Devkota et al. 2009). However 
recent extensive biochemical work has allowed the reconstitution of the more complex 
eukaryotic translation system, with a 3 Å crystal structure of a yeast ribosome recently 
reported (Ben-Shem, Jenner et al. 2010; Ben-Shem, Garreau de Loubresse et al. 2011) 
(Figure 1-7). This work has allowed insight into the specific workings of eukaryotic 
translation, revealing distinct differences from bacterial translation.
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Figure 1-6. A, P and E site occupancy during translation elongation. (A) amino-
acyl tRNA (aa-tRNA) is accommodated at the A site, and after proof-reading, peptide 
bond formation occurs (B), transferring the nascent peptide to the A site. The tRNA 
moves to the P site during translocation (C), leaving the A site empty to allow a new 
aa-tRNA to be accommodated. After the next peptide bond formation, the tRNA at the 
P site moves to the E site, and is released after the subsequent peptide bond formation. 
Figure and text adapted from (Frank and Gonzalez 2010)
A B C
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Figure 1-7. 80S ribosome.  Architecture of the 80S ribosome (A) Interface or “front 
view” of 60S and 40S subunits. Landmarks include head, body (Bd) and platform (Pt) 
of 40S as well as central protuberance (CP), L1-stalk and P-stalk of 60S. (B) Solvent-
side or “back” view of the 60S and 40S subunits. From (Ben-Shem, Garreau de 
Loubresse et al. 2011) http://www.sciencemag.org/content/334/6062/1524.full. 
Reprinted with permission from AAAS. 
Translation begins with initiation, the identification of an mRNA by  ribosomal 
components and extra-ribosomal proteins called initiation factors (eIF1-5). In eukaryotes, 
inhibitory factors prevent association of the large and small subunits until the 40S subunit 
locates a AUG start  codon. The small subunit  forms the 43S pre-initiation complex with 
tRNAmet and eIF1 and  eIF2 and GTP,  and the inhibitory factors eIF1a and eIF3. eIF4 
subunits A and G also join, and this complex interacts with eIF4E, which independently 
recognizes the 5’ cap present on most  mRNAs. eIF4E homes the pre-initiation complex to 
the mRNA; it  is released from the complex, and the pre-initiation complex then scans the 
mRNA for the start codon. Upon interaction with the AUG, the initiation factors are 
released via GTPase action of eIF5, and the 60s subunit joins the small subunit, placing 
the tRNAmet in the position (P site) to form a peptide bond with the next  amino acid 
accepted into the ribosome (at the A site) (reviewed in (Marintchev and Wagner 2005). 
Elongation, the process of joining amino acids to create a peptide, commences once the 
start codon is in the P site. Elongation requires functions of both subunits, as well as 
additional cytoplasmic elongation factors, the multi-subunit eEF1 and the translocase 
eEF2. eEF1 is a complex of subunits α, β, and γ. It interacts with all charged tRNAs and 
facilitates their interaction with the ribosome as a ternary complex with GTP. eEF1 stays 
associated with the tRNA until the decoding process in the A site is complete. The small 
subunit has a global conformational change, going from an open to closed position upon 
decoding, implying a role for specific ribosomal proteins in the progression of elongation. 
Once the tRNA has been recognized as a match for the codon on the message, eEF1 is 
21
released, and eEF2 promotes the ratcheting of the ribosome, where the small subunit 
moves relative to the large subunit. This movement advances the mRNA:tRNA through 
the ribosome and places the next codon in the A site (Figure 1-8). 
Proofreading occurs in the decoding center in the small subunit, and is mediated by the 
rRNA of the small subunit. The process provides quality control, assuring that the proper 
sequences of amino acids for the message being translated. The general mechanism is 
conserved among the kingdoms, and the basic mechanism has been illustrated in bacteria. 
The same principles are assumed to extend to eukaryotic ribosomes, although there is 
evidence that eukaryotic ribosomes, especially those of higher organisms, have additional 
elements to provide higher fidelity (Dresios, Panopoulos et  al. 2006; Ben-Shem, Jenner et 
al. 2010; Ben-Shem, Garreau de Loubresse et al. 2011)
The decoding process has several discriminatory steps, and passage through these steps is 
irreversible (reviewed in (Zaher and Green 2009). This was initially proposed as a kinetic 
mechanism, mediated by  the change in free energy associated with the codon:anticodon 
interaction and the subsequent rate of hydrolysis of GTP by elongation factor 1 (eEF1 in 
eukaryotes, Ef-Tu in prokaryotes). Here the rate of GTP hydrolysis is regulated by the 
appropriateness of the fit between the codon and the anti-codon. A perfect 
complementarity of all 3 nucleotides between the codon and anticodon results in the 
lowest change in free energy, as measured by GTP hydrolysis. A near cognate match, 
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Figure 1-8. Cognate fit; normal elongation. During normal translation elongation, 
(A) aa-tRNA selection occurs as the mRNA in the A site is decoded. Selection of a 
cognate aa-tRNA allows its accomodation into the A site of the ribosome (B). Peptide 
bond formation occurs, transferring the nascent peptide (orange line) from the P-site 
tRNA to the A site tRNA (C). (D) Translocation occurs, moving the A site tRNA to 
the P site. (E) When a stop codon enters the E site, it is not decoded by an aa-tRNA. 
A class I release factor (black oval) interacts with the mRNA and the ribosome and 
























where one base pair of the tRNA anti-codon is not a normal complement to the codon, 
requires more energy to be accommodated fully into the A site. A non-cognate tRNA, 
where there is more than one non-complementary base pair, will fail to stimulate GTP 
hydrolysis and will not linger at the A site. Cognate and near-cognate interactions induce 
a structural change in EF-Tu (and likely eEF1) which controls the rate of GTP hydrolysis; 
decreasing the rate of GTP hydrolysis has been shown to increase the accurateness of 
proofreading (Thompson and Karim 1982; Zaher and Green 2009). GTP hydrolysis 
stimulates the release of EF-Tu/eEF1 and proofreading occurs to discriminate between 
cognate and near-cognate fits. The off-rates — disassociation of tRNAs from the A site 
— are different for cognate vs. near cognate fits; the off-rate of near-cognate tRNAs after 
EF-Tu release is higher than cognate tRNAs. 
Proofreading is performed in the decoding center, formed by portions of the 16S/18S 
rRNA. A conserved set of nucleotides, G529 and G530, A1492 and A1493, are 
responsible for measuring the fit of the codon:anticodon pairing as measured by the 
minor groove of the helix formed first two bases of the codon:anticodon nucleotides. A 
proper Waston-Crick pairing of these nucleotides results in conformational changes in the 
decoding center. A1492 and A1493 and G530 change orientation and extend into the 
minor groove of codon:anticodon helix to “inspect” the fit. It has been observed that 
mismatch of the first base pair results in a less compact fit  in the decoding center (Zaher 
and Green 2009). This results in improper hydrogen bonding with A1492, and exclusion 
of water needed to solvate polar groups (Ogle, Carter et al. 2003), which results in higher 
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energy losses and enhanced off-rates. The combined actions of A1492, A1493 and G530 
have been called a ‘molecular caliper’ (Figure 1-9).  The steric dependence of all the 
elements is like the completion of a puzzle with fitting pieces. The proper fit in the 
decoding center induces the closed conformation of the small subunit, which in turn 
affects the large subunit  where the tRNAs are accommodated in the A, P and E sites. 
Some variation in third base pair of the codon is permitted, resulting in third position 
wobble associated with many  tRNA species for the same amino acid. After decoding, if 
the tRNA is not readily  disassociated from the A site, the peptide bond is formed, and the 
nascent peptide is transferred from the tRNA in the P site to the newly accommodated 
tRNA in the A site. 
Study of eukaryotic translation has suggested that although the basic mechanisms of 
decoding are the same, proof-reading may be more rigorous in higher organisms. 
Miscoding, the insertion of the wrong amino acid at a codon, occurs very infrequently in 
normal eukaryotic translation (approximately 1 error per 104 - 105 elongation steps) 
(Luce, Tschanz et al. 1985). Eukaryotic proofreading utilizes a pair of adenines (A1755 
and A1756) and a guanine residue (G530) but  other nucleotides in the decoding 
sequences differ. This variation appears to confirm resistance to aminoglycoside 
antibiotics. The recent structural data from models of eukaryotic ribosomes also indicate 
protein-mediated mechanisms to increase fidelity and maintain quality control. 
Eukaryotic rRNA segments are longer than their prokaryotic counterpart, and these 
additional sections, termed expansion sequences, form extra bridges between the 
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Figure 1-9. Decoding Center (A) Schematic of 16S decoding center with tRNAs in 
A and P site, and mRNA  Shown are the A- and P-site tRNAs as green and red strand 
ribbons, the mRNA fragment as space filled, and two segments of the 16S RNA in 
backbone (the self-folding long helix 1402–1498 (1GIX.pdb) containing the 
conserved A-1492 and A-1493 as black dots and the short segment containing G-530 
shown as a black dot. The proteins: S9 is displayed as yellow, S12 as cyan, and S13 as 
gray. (Smith, Lee et al. 2008).
A
subunits. This implies extra coordination and control between the decoding process 
occurring in the small subunit and the actions of the peptidyl transfer center in the large 
subunits. Eukaryotic specific protein moieties are also involved in the intersubunit 
interactions.  For example, a eukaryotic specific ridge is formed between the P site tRNA 
and the E site by a region of the 18S rRNA, which is shifted into the E site upon 
ratcheting.  There is no corresponding structure in the prokaryotic ribosome. It is thought 
that this mechanism prevents back-ratcheting to ensure proper progression of elongation 
and maintenance of the reading frame (Ben-Shem, Jenner et al. 2010). 
Termination of the elongation reaction occurs when a stop codon (UAG, UGA or UAA) 
enters the A site. There are no tRNAs which normally  decode these codons. In the 
absence of a cognate tRNA, a termination factor recognizes the stop codon, and 
stimulates a hydrolysis reaction which allows for the release of the peptide from the 
peptidyl tRNA. Termination requires two types of release factors. Class 1 factors are 
those which interact with the mRNA and recognize the stop codon. Prokaryotes utilize 
two Class I factors, RF1 and RF2. Both recognize the UAA stop codon, but RF1 also 
recognizes UAG; RF2 recognizes UGA. Eukaryotes have a single Class I factor, eRF1, 
which recognizes all three stop codons. All Class I factors share a GGQ motif that is 
necessary  for promoting hydrolysis in the peptidyl transferase center (Figure 1-10). 
Another domain interacts with the codon of the mRNA in the decoding site. In this way, 
release factors are similar to tRNAs. However, unlike the relatively conserved tRNA 
sequences, eukaryotic and prokaryotic Class I release factors lack homology. Because 
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Figure 1-10. eRF1 structure. (A) Movement of the GGQ motif of eRF1 (lime green, free 
state) upon binding to eRF3 (dark green, bound state). The GGQ motif is responsible for 
hydrolysis of the peptide bond and release of the nascent peptide. (B) Comparison of 
tRNA and eRF3-bound eRF1. eRF3 binding causes a bend in Domain M of eRF1 
resulting in an eRF1 conformation similar to that of a tRNA. Adapted legend and figure 
(Cheng, Saito et al. 2009). 
termination is the result  of a protein:mRNA reaction, it is thought that different regions of 
the decoding center are involved in termination; it  is not merely a mimic of the 
elongation reaction (Youngman, He et al. 2007). 
Eukaryotes and prokaryotes have a single Class II release factor each, eRF3 and F3 
respectively. Both are GTPases, but their roles in termination are very  different. F3 
promotes the disassociation from the ribosome and the recycling of RF1/2, but does not 
directly  affect termination of the elongation process.  In contrast, eRF3 makes eRF1 work 
better. Although eRF1 alone is sufficient to catalyze termination, eRF1 and eRF3 form a 
ternary complex with GTP which increases the rate of termination. Interestingly, the 
binding of eRF1/eRF3/GTP appears to affect the shape of the ribosome. The portion of 
the ribosome which protects the mRNA is pulled back, indicating a conformational 
change in the entry  site and underscoring the plasticity of the ribosome as whole. eRF3 
does not appear to contribute to the recycling of eRF1 (Alkalaeva, Pisarev et al. 2006). 
After termination, the newly translated peptide is released from the ribosome and is 
folded, modified and transported as necessary. For ribosome recycling prokaryotes utilize 
two other factors, RRF, which is essential for disassembly, and EIF3, which associates 
with the small subunit to prevent interaction with the large subunit until initiation. EIF3 
also mediates release of old tRNA and mRNAs from the small subunit (Hirokawa, 
Nijman et al. 2005; Singh, Das et al. 2005; Seshadri and Varshney 2006).  Recycling of 
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the 80S ribosome is less well understood. Eukaryotes do not express RRF or an 
homologous protein. Rather, the 80S ribosome is disassembled by ABCE1, which 
possesses general NTP hydrolysis capabilities and requires the presence of eRF1. ABCE1 
binds to the ribosome after peptide release and results in separation of the 60S subunit 
from the tRNA and mRNA bound 40S subunit (Pisarev, Hellen et  al. 2007; Pisarev, 
Skabkin et al. 2010). 
Recoding
Viral translation capitalizes on nuances of translation to promote viral protein synthesis, 
sometimes at the expense of the host translation. So far, adaptations to many aspects of 
initiation and elongation have been discovered, and many of these have been studied in 
depth. Cap-snatching (Mir, Duran et al. 2008)and the use of an IRES (Hellen and Sarnow 
2001; Hellen 2007; Hellen 2009) maximize initiation on viral mRNAs and multiple 
translation tools such as recoding, ribosome shunting (Ryabova, Pooggin et al. 2002; 
Racine and Duncan 2010), and “hiccuping” caused by the foot and mouth virus 2A 
peptide (Donnelly, Luke et al. 2001) give flexibility to a compact genome.
All retroviral translation depends on a recoding event to translate viral enzymes. These 
products  are encoded by the pol gene, which lacks its own promoter and a start codon. 
The viral enzymes are only produced as a fusion product with the gag structural protein 
precursor. The gag protein sequence terminates with a stop codon, and for translation to 
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continue into the pol region the stop  codon must be hidden or misidentified by  the 
translating ribosome. This can occur by either of two mechanisms. During a frameshift 
event the ribosome re-adjusts its position on the mRNA in response to stimulus on the 
message itself, and the stop codon in essence disappears (Figure 1-11). It  also occurs via 
a readthrough event, where the reading frame is the same, but an amino acid is placed at 
the site of termination (Figure 1-12). Both processes happen at a low frequency, which 
remarkably  corresponds with the proportion of fusion product to structural components 
needed for viral replication, and alteration of this ratio can disrupt the virus’ ability to 
replicate. 
The most extensively studied retroviral recoding event is frameshifting. A frameshift 
event alters the reading frame of the mRNA within the ribosome. The shift may  adjust the 
reading frame forward to skip  a base, i.e. the +1 frameshift of Epstein-Barr virus IL-10 
(Yoon and Walter 2007) or back to include an already decoded nucleotide as in the -1 
frameshift of HIV-1. The frameshift  event occurs on a portion of mRNA containing 
nucleotides  XXX YYY Z (X is any nucleotide, Y is an A or U, and Z is not G).  This 
motif, designated the slippery sequence, is required, but not wholly sufficient, to promote 
frameshift. The event also requires the presence of a secondary structure downstream of 
the slippery  sequence. This can be a pseudoknot, as in HTLV or a stemloop, as in HIV-1. 
The spacer region between the slippery sequence and the secondary structure varies 
slightly among viruses, but deviation from the wild-type also affects frameshifting. 
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GCU GAA AAU UCA AAA AAC UUG UAA AGG GGC AGU CCC CUA GCC CCA CUC AAA AGG GGG AUA AA
GCU GAA AAU UCA AAA AAC UUG UAA AGG GGC AGU CCC CUA GCC  CCA CUC AAA AGG GGG AUA AA
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Figure 1-11. Recoding: Frameshift. The translating ribosome encounters a slippery 
sequence upstream of a stop codon, and in response to a stimulus from a secondary 
mRNA structure, re-aligns on the mRNA in an alternate reading frame. This results in 
a nucleotide being skipped, or re-decoding as part of a new codon. In the new reading 
frame, the stop codon is re-aligned into a sense codon, and translation continues. 
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G ACC CUA GAU GAC UAG GGA GGU CAG GGU CAG GAG CCC CCC CCU GAA CC CAG GAU AAC CCU CAA AGU CGG GGG GCA ACC CGU C
!
G ACC CUA GAU GAC “CAG” GGA GGU CAG GGU CAG GAG CCC CCC CCU GAA CC CAG GAU AAC CCU CAA AGU CGG GGG GCA ACC CGU C
?
MoMLV Normal translation
MoMLV Readthrough (suppression of termination)
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Figure 1-12. Recoding: Readthrough. The translating ribosome encounters a stop 
codon upstream of a secondary mRNA structure, and allows insertion of an amino acid 
instead of termination. Translation continues in the same reading frame. 
Lentiviruses contain one frameshifting sequence at the end of gag to promote translation 
of the gag-pol fusion protein. The stop codon is not a stimulatory  factor in frameshifting; 
in HIV-1, the stop codon for gag occurs about 130 bp downstream of the slippery 
sequence/stem loop and the frameshift event. Other retroviruses, such as the 
deltaretroviruses (MMTV) and betaretroviruses (HTLV) contain two separate frameshift 
stimulatory  sequences. One occurs at the junction of gag and the coding region for the 
first of the pol products, PR, the viral protease. The second occurs at the end of the pro 
sequence and the start of the reverse transcriptase sequence. Thus, the proportions of the 
viral enzymes to structural components and to each other are more controlled than in the 
single frameshift sequences.  
Conflicting evidence about when during elongation the actual slippage of the mRNA 
occurs has resulted in the proposal of three general models of frameshift (Figure 1-13). 
Each scenario involves different states of occupancy of the A, P and E sites, and 
accommodation status of the A-site tRNA. In addition, the role of the E site tRNA is 
variable. It has been recently shown that all three models of frameshift are kinetically 
possible, and may vary according to the exact nature of the stimulatory RNA structure 
(Liao, Choi et al. 2011). However, for HIV-1, it appears that the slippage occurs because 
of incomplete translocation, and that the forces of decoding in the A site allow for 
accommodation of a tRNA that  overrides the misalignment of the codon:anticodon 
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Figure 1-13. Proposed mechanisms of -1 programmed ribosomal frameshift. Two 
translation elongation cycles are depicted at the top: the ribosome undergoes decoding 
(DC), aa-tRNA accomodation (AA), peptidyl transfer (PT) and translocation twice to 
add two amino acids into the polypeptide sequences. A shift in reading frame may occur 
at the first TL step and the ribosome decodes a -1 frame A-site codon at the recoding 
site. Additionally, a -1 PRF may occur at the second AA stop, in which the ribosome has 
decoded the zero frame A-site codon. Incorporation of the -1 reading frame aa-tRNA 
starts at the following cycle. Moreover, the shift in reading frame may occur at the 
second TL and incorporation of the -1 reading frame aa starts at the following cycle. 
(Liao, Choi et al. 2011), Laio et al, The many paths to frameshifting: kinetic modelling 
and analysis of the effects of different elongation steps on programmed -1 ribosomal 
frameshifting, Nucleic Acids Research, 2011, Vol. 39, No.1, p. 301, by permission of 
Oxford University Press. 
interactions in the P and E sites. The kinetic models were performed using 70S ribosomes 
from E coli; this mechanism may be slightly different for eukaryotic 80S ribosomes (in 
cryo-EM  samples, it is common to see promiscuous binding of any tRNA in the E site.) 
This may indicate universal non-specificity or may be a prokaryotic specific event.
Mutational studies of the coronavirus infectious bronchitis virus (IBV) frameshift 
pseudoknot revealed an additional kinetic element involved in frameshifting (Kontos, 
Napthine et al. 2001). Like HIV-1, IBV utilizes a -1 frameshift event to control 
translation of proteins (Brierley and Dos Ramos 2006). Pausing of translation occurs in 
the IBV and many other frameshift sequences and this coincides with placement of the 3’ 
portion of the slippery sequence in the A site of the ribosome (Kontos, Napthine et  al. 
2001) . The pause occurs regardless of the presence of the slippery sequence and is 
thought to be dependent on secondary structure downstream of the slippery sequence. 
The rate of translation may be slowed as the ribosomal helicase takes longer to dissolve 
the secondary structure. However, pausing occurs with mutated secondary structures that 
do not support frameshift as well (Kontos, Napthine et  al. 2001). Those secondary 
structures that induce frameshift  must provide a specific stimulus or condition for 
frameshift to occur. 
The placement of the pseudoknot at the entry of the mRNA channel on the ribosome 
results in a torsion of the mRNA:tRNA in the P site. A cryo-EM reconstruction of the 
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IBV pseudoknot on an 80S mammalian ribosome gives perhaps the most relevant 
information on the mechanisms involved (Figure 1-14) (Namy, Moran et al. 2006). 
During pausing, the edge of the pseudoknot sequence is at the beginning of the mRNA 
entry  channel of the ribosome; this is the putative location of the ribosomal helicase. The 
reconstruction captures eEF2, the translocase, in the A site, and shows a significant bend 
in the P site tRNA toward the A site. This conformational change indicates stress on the P 
site tRNA as eEF2 is promoting translocation and the unmelted PK is preventing full 
complementary  movement of the mRNA. This global change in the shape of the P site 
tRNA affects the interaction of its anticodon with the codon of the mRNA. The 
codon:anticodon interaction is broken and the mRNA readjusts in a new reading frame. 
Theoretically, because of the nature of the slippery sequence, certain non-cognate 
interactions are tolerated. 
Gammaretroviruses such as Moloney Murine Leukemia Virus (MoMLV) and 
Xenotropoic Murine Leukemia virus related virus (XMRV) and epsilonretroviruses do 
not produce the pol genes by frameshifting. Instead, these viruses utilize a readthrough 
event, where an amino acid is inserted at a stop codon (Figure 1-15). This event is distinct 
from frameshift in that the mRNA remains in the same reading frame. Readthrough in 
viruses does not seem to require a sequence in the decoding site analogous to the slippery 
sequences, as readthrough can occur with all three stop codon (though at different 
frequencies) and despite the identity of the nucleotides immediately upstream. A 
pseudoknot is absolutely required for retroviral readthrough, and particular nucleotide 
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Figure 1-14. Proposed mechanics of frameshifting pseudoknot. Three different states 
of the small subunit translating an mRNA containing a pseudoknot that induces -1 
frameshifting are shown. a. The elongating ribosome approaching the pseudoknot in the 
zero reading frame. b. Engagement with the pseudoknot, generating a frameshifting 
intermediate in which the small subunit is stalled during translocation with eEF2 bound, 
causing tension in the mRNA that bends the P-site tRNA in a (+) sense direction. As a 
result the anticodon-codon interaction breaks over the slippery sequence, allowing a 
spring-like relaxation of the tRNA in a (-) sense direction. c. Re-engagement of the 
tRNA with the mRNA, leaving the ribosome translation in the -1 reading frame.  
Reprinted by permission from Macmillan Publishers Ltd: Nature, (Namy, Moran et al. 
2006), copyright 2006. http://www.nature.com/nature/index.html
substitutions can have drastic affects on the incidence of readthrough. 
Readthrough is also referred to as stop codon suppression, and can occur in yeast and 
bacteria with a suppressor tRNA . Suppressor tRNAs contain anti-codons that align to a 
stop codon; thus they cause normal termination to be suppressed by interacting with a 
termination signal and allowing an insertion of an amino acid which propagates 
elongation. There is evidence to support the notion that suppressor tRNAs play a role in 
cellular readthrough events, and it was hypothesized that the readthrough of the gag 
termination codon in MoMLV was a result of a glutamine charged suppressor tRNA 
(Kuchino, Beier et al. 1987; Kuchino, Nishimura et al. 1988). Likewise, the concentration 
of tRNAglu suppressor was increased in certain infected cell lines. However, further 
examination refuted the role of the suppressor tRNA. Although glutamine is the 
predominant amino acid inserted during the readthrough event, other amino acids can 
also be inserted (Houck-Loomis 2009). Suppression works in viruses that  utilize UGA 
which would not be decoded by the glutamine suppressor, and also with UAA (Feng, 
Levin et al. 1989; Jones, Nemoto et al. 1989; Feng, Copeland et al. 1990).  Most 
conclusively, readthrough can occur in in vitro lysates and in cells in the absence of any 
suppressor tRNAs (Feng, Hatfield et  al. 1989). Thus the readthrough event in MoMLV 
likely involves interactions with the ribosome and/or perturbations of termination events. 
39
The MoMLV pseudoknot structure (Figure 1-16) and spacing requirements have been 
extensively  studied via mutational analysis (Feng, Yuan et al. 1992). Early analysis of the 
sequences required for the expression of gag-pol established the importance of the 
placement of the stop codon within the sequence. Movement of the stop  codon one codon 
3’ of its original position abolished readthrough. Likewise, changing the preceding  CAG 
glutamine codon (the 9th codon upstream of the normal gag stop codon) to a UAG stop 
codon also does not support readthrough (Felsenstein and Goff 1992). This indicated that 
readthrough was entirely  context  dependent. Comparison of amino acid substitutions 
from mutated virus lacking the gag-pol protein revealed that a mutation that  should allow 
for production of gag-pol with alternate codon usage was not viable; thus it was the 
nucleotide sequence and not the proteins encoded that prevented viral replication and 
production of gag-pol (Felsenstein and Goff 1988). The nature of the necessary 
nucleotides suggested the presence of stable stems in the sequence downstream of the 
stop codon. 
Additional studies introduced the likelihood of a pseudoknot structure forming during 
translation of viral mRNA (Odawara, Yoshikura et al. 1991; Wills, Gesteland et al. 1991; 
Feng, Yuan et al. 1992).  Mutational analysis of the sequences downstream of the gag-pol 
junction illustrated the sequence involved in readthrough. It was determined that a stem 
loop is present downstream of the UAG stop codon. Double compensatory mutants that 
shuffled the nucleotide sequence but  retained the putative stem loops retained the ability 






Figure 1-15. Readthrough of the MoMLV gag-pol junction. (A) The pol gene lacks a 
start codon, and is produced only as a fusion protein with the upstream gag gene 
products. The gag gene contains a stop codon, and 95% of the time, normal termination 
occurs. Suppression of termination happens at a frequency of about 5%, and allows the 
translation of the pol genes at a specific ratio to the gag only  product. (B) At the UAG 
stop codon of gag, the ribosome usually  undergoes normal termination events resulting 
in the release of the gag protein. During the readthrough event, termination is 
suppressed, allowing the accommodation of a near cognate CAG tRNA at the UAG stop 


















Figure 1-16. Schematic of MoMLV pseudoknot structure. The original proposed 
structure of the MoMLV pseudoknot downstream of the gag:pol junction, based on 
mutation analysis. The pseudoknot consists of two stems, and two loops, with an 8 
nucleotide spacer between the UAG stop codon and the start of stem 1.
pseudoknot structure to be proposed.  Interestingly, certain mutations that should have 
had little impact structurally were found to have effects on the proportion of readthrough 
(summarized in Figure 1-17) (Felsenstein and Goff 1992; Alam, Wills et al. 1999) .
Our lab has recently published an NMR structure of the MoMLV gag-pol junction and 
downstream sequence which verifies several predictions made about its structure as well 
as suggests a mechanism for its action (Houck-Loomis, Durney et al. 2011). NMR data 
confirms that the necessary nucleotides 3’ to the stop codon are capable of forming a 
classic H-type pseudoknot. The two stems are co-axial stacked, as confirmed by  proton 
walking in the spectrum. Stem 1 contains a 1X2 internal loop and is formed from bases 
G9 to C33, while A29 is an unpaired bulged nucleotide. Stem 2 contains 7 base pairs, and 
Loop 2 is made of nucleotides A34 thru C51. Interestingly, the NMR structure predicts that 
stem 1 may begin with nucleotide G5, instead of G9 as inferred from mutational studies 
(Figure 1-18). This extends stem one to include bases formerly  considered part of the 
Loop 2 structure. However the traditional proposed structure allows for placement of the 
stop codon in the A site when the edge of Stem 1 is at the entry  of the ribosome. The 
alternative NMR structure places the stop codon outside of the decoding center when the 
pseudoknot would be at the entry of the mRNA tunnel; this would suggest that the 
readthrough process starts upstream of the stop codon. Further biochemical work and/or 
structural studies will be needed to clarify the placement of the stop codon and the 


















































































Figure 1-17. Mutations to the MoMLV Pseudokn t and their effects on 
readthrough. Mutations are mapped to their locations in the high pH structure (see 
Figure 1-18 and text). Mutations in green stimulate an increase in readthrough activity; 
mutations in blue show near-wild type readthrough levels; mutations in orange display 
a mild to moderate decrease in readthrough, and mutations in red effectively abolish 
the readthrough-stimulating activity of the ribosome.  Text and modified figure 




Figure 1-18. Traditional and revised MoMLV pseudoknot structure. (A) Traditional 
schematic of MoMLV structure based on mutational analysis. (B) Revised schematic of 
MoMLV pseudoknot based on NMR and CD data. The spacer between the UAG stop 
codon and the start of stem 1 is shorter, with bases G5 to A9 becoming part of the stem 
1. G5 to C7 pair with U38 to G36 respecitively to extend Stem 1 and reduce Loop 2.  A8, 
A34 and G35 are unpaired bulges in stem 1, while the terminal base pair G5:U38 is a non-
canonical base pair. (Figure and text adapted from (Houck-Loomis 2009).
The NMR studies reveal that the pseudoknot is capable of undergoing a dramatic 
conformational shift  based on two or more protonation events, and this alternate 
conformation increases readthrough (Figure 1-19).  Protonation of A17 is verified 
through the NMR data; protonation induces an alteration of the coaxial stacking of stem 2 
and a downward shift which allow interactions between loop 2 and stem 1. This results in 
a kinked RNA motif that could putatively interact with the ribosome itself or cause a shift 
in the upstream mRNA in the decoding site to allow miscoding. Readthrough is pH 
dependent, as lower pH in IVT reactions confirms. Mutants that  raise the pKa of the 
active form of the pseudoknot show increased readthrough at higher pH levels. Therefore, 
variations in the local pH of the cell are able to induce the change in pseudoknot 
structure, and the frequency of this change is directly linked to the proportion of 
readthrough of the gag-pol junction. 
A model of the MoMLV pseudoknot gives insight into the role of the mRNA in inducing 
readthrough. But several key issues remain. The NMR structure proposes an elegant 
riboswitch phenomenon, but interactions with the ribosome and other host factors are still 
unclear. It seems likely that many other layers of regulation exist. The following work 
describes our attempts to investigate trans-acting factors that affect readthrough. Chapter 
3 documents work done on the ribosomal protein RPL4 which is able to increase 
recoding in a dose-dependent manner. Chapter 4 details the affects of aminoglycoside 
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Figure 1-19. Inactive and active conformation of the MoMLV pseudoknot. The 
MoMLV pseudoknot exists in at least two conformations. In the proposed inactive state 
(A),  A17 is unpaired and composes loop 1 and loop 2 is unstructured. In the active state 
(B), resulting from the protonation of A17 and possibly other nucleotides, A17 shifts, 
and loop 2 tucks into stem 1, resulting in a more compact structure and a downward 
shift in stem 2 (Houck-Loomis 2009). 
BA
antibiotics on readthrough of the MoMLV gag-pol junction. The appendix includes two 
additional projects, work towards a FACS based screen to find proteins which increase 
readthrough, and preliminary experiments for a proposed cryo-EM structure of the 
MoMLV PK on the ribosome.
48
Chapter 2: Materials and Methods
Tissue culture: 293A, 293T, Rat2, Hela, Te671, A549, Sirc and BHK cells were grown 
in DMEM  with 10% FBS supplemented with L-glutamine plus pencillin/streptomycin. 
NIH3T3 were grown in DMEM  suppplemented with 10% BCS supplemented with L-
glutamine plus pencillin/streptomycin. Cells were maintained in a 5% CO2 atmosphere at 
37°C, and passaged at approximately 70% confluency.
Transfections: 
Cells were plated at densities of 10,000 cells per well for 96 well plates or 250,000 cells 
per well for 6 well plates the day  before transfection. Cells were transfected with Fugene 
6 Transfection reagent (Roche) at a ratio of 3 ul Fugene:1 ug DNA, and harvested for 
dual luciferase assays, q-PCR, or western blotting 24 post transfection. Assays conducted 
in 96 well plates were transfected with 100 ng experimental or reporter and 60, 120, or 
240 ng of ribosomal protein or release factor expression vector, 1.02 ul Fugene 6 and 
Optimem Serum free media to 15 ul total volume, and 3 wells were transfected with each 
transfection mix.  Assays conducted in 6 well plates were transfected with 1 ug 
experimental or control reporter, and 1, 3, or 6 ug ribosomal protein or release factor 
expression vector with 21 ul Fugene 6 and 72 ul Optimem serum free media.  All 
transfections were adjusted with empty  vector to contain the same total DNA per well per 
experiment. Cells were lysed with Promega Passive Lysis buffer. 
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Dual Luciferase Assay:
Cell lysates from transfections were transferred to opaque 96 well plates. For 
transfections done in 96 well format, cells were lysed with 20 ul Passive Lysis Buffer, 
and 15 ul from each well was transferred. Assays performed in 6 well plates were lysed 
with 150 ul Passive Lysis Buffer, and 20 ul from each well was plated in triplicate. Dual 
luciferase assays were performed using Promega Dual Luciferase kit with buffers diluted 
1:4 or 1:2 with dH20. Assays were read on Berthold or Omega plate reader for a 24 
second interval per well, with readings taken every half second for a total of 48 reading. 
One hundred microliters of firefly  luciferase reagent was dispensed for the first  12 
seconds. Firefly  signal was quenched by renilla luciferase reagent addition at 12. 5 
seconds. Values from each interval of firefly and renilla luciferase were summed in the 
Omega Mars Data Analysis program and exported to a spreadsheet program (Excel or 
Numbers) for analysis. 
Plasmids: 13PK6 and HIV-1 experimental and control reporter constructs in p2luc, 
mouse RPL4 and RPS3a in pcDNA 4, myc-tagged ribosomal proteins and MoMLV 2FP 
pQCXIP were generous gifts from former Goff lab member Brian Houck-Loomis. UPF1 
dominant negative mutants and the RSE C fragment insert were generous gifts from Goff 
lab member Bobby Hogg. Sindbis, 13ScrPK6, 13ScrPK6_RSE and CollStop dual 
luciferase reporter constructs were cloned into p2luc.  Mouse Rpl4 and Rps3a cloned into 
pcDNA4 were used for cell line assay, and into pcDNA3.1 for IVT reactions. Ribosomal 
proteins without c-terminal myc tags, human Rpl4, RPL4 mutants, PABP, eRF1 and eRF3 
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were cloned into pcDNA3.1.  Cloning was completed using Sequence and Ligation 
Independent Cloning (SLIC) protocols adapted from the Elledge lab (Li and Elledge 
2007). A complete list of inserts is located at  the end of the Materials and Methods 
section. All cloning products were verified with DNA sequencing. 
q-PCR: RPL4 expression: Primers were designed specifically against mouse L4, at the 
junction of exons 3 and 4 using Primer3 software.  293A cells were transfected with the 
RPL4 expression vector and mRNA was extracted using Trizol according to 
manufacturer’s instructions, and reverse-transcribed into cDNA with Superscript  III First 
Strand Synthesis for RT-PCR (Invitrogen.) cDNA was mixed with Fast Start SYBR green 
Master (ROX) (Roche) according to manufacturer’s instructions and analyzed for levels 
of RPL4 and actin mRNA. Assay was run on a 7500 Fast Real time PCR System 
(Applied Biosystems). 
28S rRNA expression: Primers to 28s rRNA were designed using Primer3 software. Cells 
were transfected with 6 ug RPL4 expression vector, and cDNA was produced from 
endogenous and transfected cells as described above. cDNAs were analyzed for RPL4 
and actin mRNA and 28S rRNA. Assays were run on an epGradient  S Mastercycler 
(Eppendorf) and analyzed with Realplex software. 
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Western Blots
For ribosomal expression assays, cells were plated at 250,000 cells per well the day 
before transfection and transfected with expression constructs and/or empty vector as 
described in text. Cells were lysed 6, 10, 24 and 48 hours post transfection for time 
course, and 24 hours for other proteins with RIPA buffer and protein levels were 
normalized by Bradford assay. Lysates were boiled for 5 minutes with 1X sample buffer 
and run on a 12% bis-acrylamide gel in protein electrophoresis buffer. Gels were 
transferred to PVDF membranes activated with methanol and equilibrated in phosphate 
transfer buffer. Membranes were probed with anti-RPL4 rabbit polyclonal (11302-1-AP 
ProteinTech Group) or mouse monoclonal antibody (Sigma 4A3), anti-RPL10 mouse 
antibody (Abcam ab-55544), anti-actin mouse antibody (Sigma A1978), anti-tubulin 
mouse antibody (Sigma T6199), anti-mouse myc antibody (Santa Cruz 9E10) or anti-flag 
mouse antibody (Sigma M2), anti-GST mouse antibody (Covance MNS-112P) and 
species appropriate near-infrared antibodies from Licor. Blots were visualized on the 
Licor Odyssey Imaging system. Quantification of actin and RPL4 signals was performed 
using Odyssey imaging software and Excel. 
For viral replication assays 293T cells were transfected were transfected with 1 ug 
MoMLV provirus pNCS and 1, 3, or 5 ugs mL4 or S3a and lysed with RIPA buffer with 
protease inhibitors 48 hours post transfection.  Supernatants of transfected cells were 
clarified through a 45 micron filter.  Virus was pelleted from clarified supernatants by 
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ultracentrifugation through 20% sucrose PBS at 25K in a Beckman Coulter SW-55 rotor 
for 2 hours, and recovered in 40 ul SDS containing sample buffer.  Protein levels of cell 
lysates were normalized by Bradford assay.  Samples were run on 12% gels and 
transferred onto Immobilon-FL PVDF membranes (Millipore). Western blots were 
probed with (R187) rat anti-capsid monoclonal antibody, and mouse anti-actin (Sigma 
1978) for loading controls for cell lysates, and species appropriate fluorescent antibodies 
from LI-COR.  Bots were visualized on the Odyssey Imaging system (LI-COR).
For detection of small peptides from CEMPK constructs,  TnT reaction mixes of CEMPK 
constructs were loaded in BioRd Criterion 16.5% Tris-Tricine gels, and run with MES 
buffer at 50 mA for 3.5 hours. Lysates run with Transcend tRNA lys were imaged on the 
Typhoon Scanner.
In Vitro Translation Reactions: mRNAs of 13PK6 and HIV-1 experimental and reporter 
constructs, RPL4, RPS3a, and CEMPK were transcribed using mMessage mMachine T7 
kit  and Poly (A) Tailing kit according manufacturer’s instructions. mRNA was recovered 
using a MegaClear kit (Ambion). The integrity of the mRNA was checked on an 1% 
agarose gel prepared with Northern Max buffer with SYBR safe dye; samples and marker 
were treated with glyoxal for 30 minutes at 50° C prior to loading.  For  RPL4 effects and 
CEMPK samples, mRNA was translated in Ambion Retic Lysate IVT using 0.5 ul 20X 
translation mix (-) methionine, 0.2 ul 50X methionine, 6.8 ul retic lysate, and 1 ug total 
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mRNA with nuclease free water to make volume up to 10 ul. Lysates were incubated at 
30° C for 75 minutes. For dual luciferase analysis, lysates were diluted with 30 ul passive 
lysis buffer after the translation reaction and plated at 10 ul, three times, in 96 well plates 
and read on the Omeg plate reader as per standard dual luciferase assay. 
In vitro reaction using TnT (Transcription and Translation) reagents (Promega) were 
assembled as follows: 12.5 ul lysate, 1.0 ul TnT buffer, 0.5 ul TnT T7 RNA polymerase, 
0.5 ul amino acid mix (equal parts  (-) met, (-) lys, (-) - cys mixes), 1.0 ul reporter DNA, 
1.0 additional DNA if need (for RPL4 tests), nuclease free water up to volume of 25 ul. 
Reactions were incubated for 2 hours at 30° C. Dual luciferase assays. For reactions 
using Transcend tRNA (Promega), 0.5 ul, Transend tRNAlys was added and water 
volume was adjusted. 
 
For in-vitro drug experiments, TnT reagents were combined as follows: 6.25 ul lysate, 0.5 
ul TnT buffer, 0.25 ul TnT T7 polymerase, 0.25 ul amino acid mix, 0.25 reporter DNA, 
4.5 ul nuclease-free water,  0.5 ug drug. Reactions were incubated for 2 hours at 30° C. 
Reactions were diluted with Passive Lysis Buffer (Promega) and assayed by dual 
luciferase protocols as described. 
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GST-tagged Protein Synthesis: RPL4, RPS3a, Gluthaminyl Synthetase, Methionyl 
Synthetase, and Lysyl Synthetase were cloned in the pGEX N-terminal GST containing 
expression vector. E Coli strain BL21 was transformed with each plasmid (1 ug added to 
100 ul bacteria, incubated on ice for 30’) and cultures were grown overnight in ampicillin 
media at 37° C. Cultures were diluted 1:10 and grown until O.D. of 200. ITPG was added 
to final concentration of 0.1 mM and cultures were grown for 4 hours at 30° C on a 
shaker. Bacteria was pelleted, and resuspended in TBS with 0.5 mM DTT and protease 
inhibitors. Solution was sonicated on ice, for 15 secs, 4 times, and centrifuged, and 
supernatant was collected for soluble proteins. Supernatant was combined with 
glutathione-agarose beads, and incubated on a rocker overnight at 4°C. 
eRF1 immunodepletion of IVT lysates: Sigma (E8156) and Abcam (ab30928) 
antibodies to eRF1 were added in 1:25 (1.6 ul) and 1:50 (0.8 ul) concentations to 40 ul 
retic lysate and incubated overnight at 4° C on a rocker. Lysates were added to 40 ul PBS 
washed Protein A sepharose beads, and incubated on a rocker for 2 houts at 4° C. Lysate 
was recovered after 3 mins spin at 4° C and frozen at -80° if not used immediately.
tRNA depletion of IVT lysates: Ethanolamine blocked epoxy-activated Sepharose 
column was prepared as follows: 2 ml epoxy-activated sepharose beads were swollen in 
dH20 for 15 minutes, and washed 5X with dH20 to remove preservative. Beads were 
resuspended in 1M ethanolamine and incubated overnight at room temperature on a 
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rocker. Beads were washed until wash was at a pH of 7. For tRNA depletion of IVT 
translation mix, ethanolamine blocked beads were washed 2X with 10X volume Buffer A 
supplemented wiht 80 mM KOAc and 0.5 mM Mg(OAC)2. IVT lysate was diluted to 
70% original concentration, and mixed 1:1.3 with bead slurry, and mixed on rocker for 1 
hr at 4°. Lysate was recovered and used for TnT reactions. 
 
Immunoprecipitation of flag-tagged RPL4: Cells were transfected with 6 ug RPL4 
expression vectors as described. 24 hours after transfection, cells were lysed with IP lysis 
buffer or Passive Lysis buffer, and 75 ul lysate was combined with 50 ul washed and pre-
cleared protein G beads and 1.5 ul Sigma anti-flag F3145, and incubated overnight.  
Alternately, lysates were incubated with anti-Flag M2 beads (Sigma). Beads were boiled 
with 5X sample buffer and analyzed via Western blotting as described. 
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Nucleotides in bold denote stop and corresponding sense codons in experimental and 
control dual luciferase reporters.
* Native protein coding sequence. C-terminal myc-tagged inserts eliminate the stop 
codon to allow translation of the myc epitope. 
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Chapter 3: RPL4 effects on retroviral recoding
In an attempt to understand the cellular role in the phenomenon of readthrough, our lab 
conducted a yeast 3-hybrid screen (Bernstein, Buter et al. 2002) to find host factors that 
interact with the MoMLV pseudoknot mRNA.  Briefly, the bait was designed as the 
MoMLV PK RNA transcriptionally fused to the MS-2 stem loop.  The MS-2 RNA motif 
interacts with a hybrid protein of the MS-2 RNA-binding coat protein and Lex-A DNA 
binding protein, tethering the bait upstream of His3 and LacZ reporters on the yeast 
chromosome. The prey consisted of a hybrid protein containing the activation domain of 
the Gal4 transcription factor fused to coding sequences from a pooled plasmid mouse 
cDNA library. An interaction between RNA bait and protein prey results in translation of 
the reporter genes that can be detected by growth on his(-) media and verified by positive 
X-gal staining. From over 200 positive hits, we focused on two that showed high levels 
of reporter activity. Large ribosomal protein 4 (RPL4) was recovered for its ability  to 
interact with the MoMLV pseudoknot sequence; in particular the C-terminus of the 
protein was found to bind RNA. RPL4 was also able to bind a no-pseudoknot control, as 
verified in gel shift assays, though the strength or frequency of the interaction has not 
been tested (Houck-Loomis 2009). Small ribosomal protein 3a (RPS3a) was also 
recovered. 
RPL4 is highly conserved among all kingdoms (Lecompte, Ripp et al. 2002). In bacteria, 
RPL4 lines the exit tunnel of the ribosome, and has extensions near the peptidyl 
transferase center (Zengel 2003), and eukaryotic RPL4 appears to occupy a similar 
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position in the 80S ribosome (Taylor, Devkota et al. 2009; Ben-Shem, Garreau de 
Loubresse et al. 2011; Klinge, Voigts-Hoffmann et al. 2011) (Figure 3-1). The eukaryotic 
version of RPL4 has a large extension that is not present in the prokaryotic protein and is 
located in close proximity  to the peptidyl transferase center and is interconnected to 
eukaryotic specific extensions of other large subunits proteins which ring the peptide exit 
tunnel. Single point mutations in bacterial RPL4 can confer antibiotic resistance in E. coli 
although there appears to be no direct contact between RPL4 and the decoding center 
where aminoglycosides interact with the ribosome (O'Connor 2004) .  Mouse RPL4 has 
been shown to interact with helicase Gu alpha in the nucleolus and to have a role in the 
processing of ribosomal RNA (Yang, Henning et al. 2005). It also has a nuclear function, 
increasing the transcription of myb-regulated genes (Egoh, Nosuke Kanesashi et al. 
2010). 
To measure changes RPL4 might have on readthrough efficiency, we employed a dual 
luciferase assay with a two-plasmid reporter system (Grentzmann, Ingram et al. 1998). 
The MoMLV gag stop codon and pseudoknot sequence was cloned into a plasmid 
between Renilla and firefly  luciferase coding sequences, thus allowing expression of 
firefly luciferase only  when the readthrough event has occurred (Figure 3-2), paralleling 
the expression of gag and gag-pol. To control for effects on overall translation, and to 
allow normalization of basal readthrough levels independently of background or 
transfection efficiency, we also constructed a control plasmid containing the same 
MoMLV sequence with a glutamine codon replacing the wild type stop  codon; the control 
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Figure 3-1. Architecture of 60S Ribosomal subunit and detail of RPL4.                
(A)View of the solvent exposed side of the 60S subunit., RPL4 circled in green (B)  
Evolutionary representation of RPL4; protein core found in all kingdoms are depicted 
in light blue, protein extensions unique to eukaryotes are in red. Positions of the N and 
C terminus are indicated.  From (Klinge, Voigts-Hoffmann et al. 2011). Reprinted 
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Figure 3-2. Schematic of 13PK6 luciferase assay reporter constructs and 
calculation of readthrough. (A) The dual luciferase reporters contain 83 base pairs of 
of the MoMLV gag:pol junction, with 13 base pairs before the UAG stop codon and 6 
base pairs after the end of stem 2 of the pseudoknot structure. The gag:pol junction 
sequence is between the renilla luciferase and firefly luciferase genes, allowing 
translation of firefly luciferase only when a readthrough event occurs. The 
experimental/wildtype construct contains the UAG stop codon, and the control 
construct substitutes a glutamine CAG to allow maximum translation of firefly 
luciferase to allow for normalization. (B) Readthrough efficiency is calculated as the 
ratio of firefly to renilla luciferase signals from the experimental construct divided by 
ratio of firefly to renilla luciferase signals from the control construct, multiplied by 100 
to give percent readthrough. 
plasmid was transfected in parallel into separate cells. Percent readthrough was calculated 
as the ratio of firefly:renilla signal from wild-type sequence divided by the ratio of 
firefly:renilla signal from control sequence multiplied by 100.  A series of plasmids 
containing various lengths of the sequences upstream of the gag stop codon and after the 
pseudoknot structure were initially tested. Flanking sequences affect the amount of 
readthrough, and the 13PK6 reporter pair (13 amino acids before the stop codon and 6 
amino acids after) was chosen as readthrough levels were most consistent and were 
equivalent with those obtained with longer sequences (Houck-Loomis 2009). 
mRPL4 enhances readthrough at the MoMLV gag:gag-pol junction.
To investigate whether the interaction between RPL4 and the pseudoknot had a functional 
effect, an expression vector for mouse RPL4 was transfected into 293A cells along with 
the 13PK6 and 13PK6-C reporter plasmids. Results of the dual luciferase assay (DLA) 
showed a dose dependent increase in the amount of readthrough that correlated with the 
amount of RPL4 transfected (Figure 3-3). Readthrough increased from a basal level of 
about 4% to over 9% in cells transfected with the maximum amount of RPL4 cDNA. 
Small ribosomal protein 3a (S3a), which was also a hit in the yeast 3-hybrid screen, was 
transfected in parallel in separate cells as a control. S3a transfection did not result in an 
increase in readthrough.  Raw values of firefly  and Renilla luciferase indicate that the 






Figure 3-3. mRPL4 effects on readthrough of MoMLV gag-pol junction.
(A) Dual luciferase analysis of readthrough of MoMLV pseudoknot and control 
reporter constructs 13PK6 and 13PK6-C transfected into HEK 293A cells, transfected 
in 96-well format. Error bars correspond to standard deviation of averages derived 
from 3 wells transfected with either wild-type or control reporter. (B) Raw values of 
luciferase from transfection in figure A. Fluc and Rluc refer respectively to firefly and 
renilla values of the wild-type reporter; Fluc control and Rluc control correspond to 





RPL4 effects on readthrough are cell line dependent
To investigate whether enhancement of readthrough was a universal effect we tested 
RPL4 and RPS3a in a number of cell lines from different species and tissues (Table 3-1). 
RPL4 increased readthrough in many, but not all, cell lines tested (Figure 3-4). 
Differences were not attributable to species or lineage of cell types; both mRPL4-
responding and non-responding groups contained human, rodent, fibroblasts, and tumor-
derived or transformed cells. Mouse and human cells responded to mRPL4 transfection 
with increased readthrough of 13PK6, indicating that the effect seen in 293A cells was 
not attributable solely  to a mouse protein being transfected into a human line. 
Additionally, RPL4 did not increase readthrough in several human cell lines tested 
(HeLa, Te671, A549). Although these non-responding cells were all tumor derived, RPL4 
did not increase readthrough in Rat2 fibroblast cells, nor in other mouse lines tested (data 
not shown). Variations in absolute values of luciferase signals indicated that transfection 
efficiencies or other conditions may have affected basal levels of readthrough; however, 
there was no correlation between response to RPL4 and basal levels of readthrough. All 
signals were well above background and within the linear range of the assay. 
There was a surprisingly wide range in the basal level of readthrough among the cell lines 
surveyed. Among the non-responding lines, basal readthrough ranged from 5% to greater 
than 10%. In responding cell lines the range was lower, from 3% to 7%. All cell lines 
were transfected with S3a as a negative control and showed no increase in readthrough 
(data not shown). The variety  in response suggests that readthrough may be modulated by 
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Cell line Species Tissue type
293A human embryonic kidney
293T human embryonic kidney transformed with 
T antigen
A549 human lung carcinoma
Balb mouse embryonic fibroblast
BHK hamster kidney
HeLa human cervical carcinoma
La-4 mouse lung adenoma
NH3T3 mouse embryonic fibroblast
Sirc rabbit corneal epitheluem
Te671 human medullablastoma
Rat2 rat embryonic fibroblast
















































































































Figure 3-4. RPL4 effects on MoMLV gag-pol readthrough: cell line survey.
(A) Dual luciferase analysis of readthrough of MoMLV pseudoknot and control 
reporter constructs 13PK6 and 13PK6-C transfected into a panel of rodent, rabbit and 
human cell lines with increasing amounts of mRPL4 cDNA. Graph is average of 2-4 
experiments for each cell line, transfected in 96-well format. (B) Raw values of 
luciferase from reporter only vector control (VC) for each experiments used in (A). 
Fluc control and Rluc control correspond to firefly and renilla values of the control 
reporter. 
additional cellular factors, and is not purely a cis-acting function of the pseudoknot-
containing viral mRNA. 
At the time of this work, xenonotropic murine leukemia-like virus (XMRV) had been 
recently  discovered and its role in prostate cancer (Urisman, Molinaro et  al. 2006) and 
chronic fatigue syndrome (Lombardi, Ruscetti et  al. 2009) was being evaluated. XMRV 
and MoMLV share the same sequence at  the gag-pol junction; XMRV also utilizes 
readthrough for expression of gag-pol. Retroviruses known to cause pathology in humans 
employ frameshift; XMRV offered an opportunity to study  readthrough in a human 
system.   Thus we choose the human cell line 293A for the majority  of our experiments in 
anticipation that our work might  be directly applicable to human disease. 
Mouse and human RPL4 both enhance MoMLV/XMRV gag-pol readthrough
RPL4 is considered a conserved protein among kingdoms, and the overall sequence is 
very similar among mammals. The N-terminal region from amino acids 1-350 are 
essentially  identical between mouse and human (residue 170 is glutamate and 208 is 
methionine in mouse, leucine and isoleucine respectively  in human) and the human 
protein is slightly longer overall.  The C-terminal 17 amino acids, as well several other 
lysine-containing regions close to the C-terminus, are identical. We cloned the human 
version (hRPL4) and transfected it into 293A cells with the DLA reporter constructs; 




Figure 3-5. mRPL4 and hRPL4 induced increase of MoMLV gag-pol readthrough.
(A) Fold change in readthrough of 13PK6 and 13PK6-C transfected into 293A with 
increasing amounts of mouse RPL4 or human RPL4. Data shown from single 
representative experiments. Fold change calculated from readthrough level in +m/
hRPL4 conditions divided by basal readthrough. (B) Raw values of luciferase for 
mouse RPL4 transfection used for (A). (C) Raw values of luciferase for human RPL4 
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RPL4 enhancement of readthrough is distinctive among ribosomal proteins
To address whether the increase in readthrough with mRPL4 was a general consequence 
of over-expression of a ribosomal protein we repeated the dual-luciferase assay with 
additional ribosomal proteins. The proteins chosen included several with known extra-
ribosomal functions, and also some with native positions deep within the ribosome. 
Transfection of 293A cells with cDNAs encoding these proteins resulted in no significant 
increase in readthrough, in contrast  to the level of enhancement seen with RPL4 (Figure 
3-6). With the exception of the acidic stalk protein RPLP0, transfection of cDNAs for all 
proteins gave similar levels in raw reporter luciferase values .
 To verify that the cDNAs were being expressed, c-terminal myc-tagged versions of all 
proteins were constructed, and tested in the DLA system. However, addition of the C-
terminal myc tag to RPL4 abolished the enhancement of readthrough, and reduced the 
slight increase seen with S20 and L7 to the basal level; effects of all other tagged 
ribosomal proteins corresponded with the non-tagged version (Figure 3-7).  Expression of 
the myc-tagged proteins, with the exception of L22, was virtually undetectable by 
western blot (Figure 3-8). This suggests that expression of many  of these ribosomal 
proteins is tightly  regulated; it may not be possible to accumulate a detectable above-
normal amount in vivo. The addition of the tag may inhibit proper folding of the proteins 














































































































Figure 3-6. Survey of effect of additional ribosomal proteins on MoMLV gag-pol 
readthrough. (A) Readthrough percentages based on dual luciferase assay results of 
MoMLV pseudoknot and control reporter constructs 13PK6 and 13PK6-C co-transfected 
with increasing amounts of ribosomal protein cDNA in 293A cells in 96 well format. 
Graph shows representative experiments of at least 3 assays with each protein. Error bars 
correspond to standard deviation of averages derived from triplicate readings of each 
condition. (B) Raw values of luciferase values for reporter only (VC) controls for 




































































































































Figure 3-7. Effect of myc-tagged ribosomal proteins on MoMLV readthrough.           
(A) Readthrough percentages based on dual luciferase assay results of MoMLV 
pseudoknot and control reporter constructs 13PK6 and 13PK6-C co-transfected with 
increasing amounts of myc-tagged ribosomal protein cDNA in 293A cells in 96 well 
format. Graph shows representative experiment,  error bars denote standard deviation of 
averages from 3 wells transfected with either wild-type or control reporter. (B) Raw 
values of luciferase values for reporter only (VC) controls for experiments used in (A). 
86
Figure 3-8. Expression of myc-tagged ribosomal proteins: western blot of myc-
tagged ribosomal proteins. 293A cells were co-transfected with 6 ug of each myc-
tagged ribosomal protein and 1 ug 13PK6 or 13PK6-C in 6 well format. 40 mg of 
total protein was loaded into each lane, and blots were probed with anti-myc antibody. 





We next prepared an N-terminal Flag-tagged version of RPL4. We transfected 293A cells 
with the Flag-tagged RPL4 and the 13PK6 reporter pair, and performed the DLA. In 
multiple retrials we saw no increase in readthrough with an N-terminal tagged mRPL4, 
and we were only able to see able to see faint expression of this construct via western 
blot.  We subsequently re-cloned RPL4 into a new 3X N-terminal flag vector.  We could 
see robust expression of this construct via western blot. However, as we observed before, 
the 3X N-terminal flag tagged RPL4 did not increase readthrough in the DLA (Figure 
3-9). 
In an attempt to avoid use of tags, we obtained several commercial antibodies against 
human/mouse RPL4, and examined lysates via western blot. Although we could visualize 
RPL4, we could not detect a significant increase in protein levels corresponding to 
increased transfection of either mouse or human RPL4 cDNA (Figure 3-10). As an 
alternate method, we performed q-PCR on RNA obtained from 293A cells transfected 
with mouse RPL4. To distinguish between endogenous and induced expression of RPL4 
we designed primers to a region unique to the mouse protein. Transfection of increasing 
levels of mouse RPL4 cDNA resulted in proportional increases in levels of mouse RPL4 
mRNA accumulating in the cells (Figure 3-11). Therefore, we can be confident that the 
RPL4 transcript is produced by the expression plasmid. However, we cannot detect any 
increase in protein levels.  












































































Figure 3-9. Expression of N-terminal Flag-tagged RPL4. (A) Readthrough 
percentages based on dual luciferase assay results of MoMLV pseudoknot and control 
reporter constructs 13PK6 and 13PK6-C co-transfected with 6 ug of p2tag flag-tagged 
or untagged mRPL4 in 293A cells in 6 well format. (B) Western blot of lysates 
transfected with tagged mRPL4 or untagged hRPL4 and 13PK6 reporter pair. Flag 
tagged lysates were immunoprecipitated with anti-Flag beads and lysates were blotted 
with poly-clonal anti RPL4.  (C) Readthrough percentages based on dual luciferase 
assay results of MoMLV pseudoknot and control reporter constructs 13PK6 and 
13PK6-C co-transfected with 6 ug of 3X-flag-tagged or untagged mRPL4 in 293A cells 





































Figure 3-10. Expression of mRPL4 and hRLP4. (A)Western blot of lysates from 
293A cells transfected with 6 ug of mRPL4 or hRPL4 and the 13PK6 reporter pair. (B) 
Readthrough from cells in (A) analyzed by DLA. (C) Quantification of signals from 





















Figure 3-11. qPCR analysis of RPL4 mRNA levels in 293 cells. Cells were 
transfected mRPL4 expression vector and harvested 24 hours later for qPCR 
analysis. mRPL4 mRNA signals were normalized to actin mRNA expression. 
vector only
over-expression of protein, we considered that the effect on readthrough could be induced 
by the RNA itself. RPL4 regulates it own transcription in bacteria (Zengel and Lindahl 
1992; Zengel, Vorozheikina et al. 1995); we hypothesized that the increased levels of 
transcribed mRNA may not be translated, but that  the RNA itself could be interacting 
with the translation machinery  to enhance readthrough. We designed an RPL4 frameshift 
(L4-FS) mutant by deleting the 11th nucleotide from the coding sequence; the sequence 
downstream of the deletion has an artificially +1 shifted reading frame that contains 
multiple stop codons (Figure 3-12). This produces an mRNA with essentially the same 
sequence, retaining the overall secondary structure, but the altered coding sequence 
results in a different, shorter protein. Transfection of the L4-FS into 293A cells did not 
significantly increase readthrough of the 13PK6 reporter pair over basal levels (Figure 
3-13) . Thus, increased readthrough is likely not caused by the RPL4 mRNA.
RPL4 mutants do not increase readthrough
Concurrent with our efforts to visualize L4 overexpression, we cloned two panels of L4 
mutants to try to define regions essential for the increase in readthrough. Initial work in 
our lab showed a requirement for the N terminus of RPL4 (Houck-Loomis 2009); 
versions of RPL4 with deletion of the N-terminus failed to stimulate an increase in 
readthrough. This work was done before the availability  of RPL4 antibodies, so 
expression of the mutants was not verified. However, it  is likely that this region is 
necessary  since the 3X terminal flag tagged versions of full-length RPL4 were produced 




ATG GCT  TGT GCC CGT CCC CTC ATA TCG GTG TAC TCC GAA AAG GGA GAG TCA 
TCT GGC AAG AAT GTC ACT TTG CCA GCT GTG TTC AAA GCT CCC ATT CGA CCA GAT 
ATT GTG AAC TTC GTT CAC ACC AAC TTG AGG AAA AAC AAC AGA CAG CCC TAT GCC 
GTC AGT  . . .
RPL4
MACARPLISVYSEKGESSGKNVTLPAVFKAPIRPDIVNFVHTNLRKNNRQPYAVSELA. . . . . . . .
RPL4-FS
MACAVPSYRCTPKRESHLARMSLCQLCSKLPFDQIL*TSFTPT*GKTTDSPMPSVNW . . . . . . .
Figure 3-12. RPL4-FS mutant. (A). The beginning portion of the mRPL4 coding 
sequence. The RPL4-FS mutant was constructed by eliminating the 11th base from the 
coding sequence. The secondary structure of the mRNA should remain relatively 
unchanged from the single deletion (B) The N-terminal region of the normal RPL4 
protein. (C) The N-terminal region of RPL4-FS. The RPL4-FS has a different peptide 






























Figure 3-13. Effect of L4-FS on readthrough of the MoMLV gag-pol junction. 
Readthrough percentages based on dual luciferase assay results of MoMLV 13PK6 
reporter pair co-transfected with 6 ug of mRPL4 or mRPL4-FS n 293A cells in 6 well 
format. Graph shows representative experiment. 
Similarly, we designed a series of RPL4 mutants that were truncated at the C terminus. 
We designed these mutants to end the protein at the start of regions of non-homology 
between the mouse and the human version (Figure 3-14). None of the C-terminal 
truncation mutants supported a significant increase in readthrough (Figure 3-15). This 
result correlates with the C-terminal myc-tagged RPL4 result, indicating a requirement 
for the C terminus of the protein. We were not able to see expression of these mutants via 
Western blot. 
RPL4 interacts directly  with helicase Guα to facilitate rRNA processing in the nucleolus 
(Yang, Henning et al. 2005) and therefore we thought perhaps RPL4 could also interact 
with the ribosomal helicase or another helicase which may  be involved in unwinding the 
pseudoknot structure. Yang et. al. mapped the region of RPL4 that binds to Guα to amino 
acids 264-428. We designed 4 mutants in which portions of or the entire of this region 
were deleted (Figure 3-16). We tested these mutants in the dual luciferase system. No 
increase in readthrough was seen with the mutants (Figure 3-17). We were not able to 
directly  visualize expression of the altered proteins; the deletions may have been extreme 
enough to prevent the proteins from proper folding or to induce another measure of 
quality control. Therefore, the importance of the helicase binding domain can not be 
evaluated from these experiments. Additionally, the deletions substantially  decreased the 
length of the protein, which may be a defining property in the promotion of readthrough.
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Figure 3-14: C-terminal differences between mouse and human RPL4 and 
schematic of RPL4 c-terminal truncation mutants. (A) Alignment of C-terminal 
regions of mouse and human RPL4. The first 340 base pairs are essentially identical 





















Figure 3-15. RPL4 C-terminal truncation mutants effect on readthrough. 
Readthrough percentages based on dual luciferase assay results of MoMLV 13PK6 
reporter pair co-transfected with 6 ug of mRPL4 or C-terminal truncation mutants in 
293A cells in 6 well format. Graph represents summary of 3+ independent 
experiments. Error bars denote standard deviation. 
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Figure 3-16. Schematic of RPL4 helicase-binding domain mutants. The helicase-
binding domain has been mapped to amino acids 264 to 333. Straight lines denote 







































Figure 3-17. Effect of RPL4 helicase-binding domain mutants on MoMLV gag-pol 
readthrough. Readthrough percentages based on dual luciferase assay results of 
MoMLV 13PK6 reporter pair co-transfected with 6 ug of mRPL4 or helicase-binding 
domain mutants in 293A cells in 6 well format. Graph shows representative 
experiment. 
RPL4 Time Course
It was observed previously in our lab that increased expression of RPL4 is likely  down-
regulated over time. Attempts by a former lab member to create a stably over-expressing 
cell line revealed that the increase in readthrough is limited to approximately 48 hours. 
In addition, the obstacles to visualizing RPL4 levels complicated the verification of over-
expression. We normally  harvest  the lysates from our transfections at 24 hours, so we 
wondered if an early  spike in RPL4 over-expression was responsible for starting a series 
of events that resulted in increased readthrough. We theorized that perhaps by the time we 
harvested samples for Western blot the expression of RPL4 returned to normal levels, but 
downstream effects were still present. We thus conducted a time course to observe levels 
of readthrough and corresponding levels of RPL4. 
We transfected 293A cells with RPL4, and took samples for DLA and WB analysis at 
various time points. Readthrough reached the highest level at 24 hours with co-
transfection of RPL4 (Figure 3-18). To measure RPL4 expression, we quantified the 
intensity of the RPL4 signal and compared it to the intensity of the actin signal in the 
western blots. Quantification of RPL4:actin showed the highest expression at 24 hours 
compared to other time points during the trial. This ratio was much lower than the level 
of RPL4:actin in untransfected cells, as seen previously (Figure 3-10) which may be an 
artifact of transfection. However, we were able to verify  that  timing of our DLA and WB 
assays were correct: we were not missing the peak of the effect  or an early  spike in RPL4 
















Figure 3-18: Timecourse of RPL4 enhancement of readthrough and 
corresponding RPL4 expression. (A) Readthrough of 13PK6 reporter pair in 293A 
cells co-transfected with 6 ug hRPL4.  (B) Western blot analysis of human RPL4 in 
293A cells; lysates were blotted with poly-clonal anti-RPL4 and anti-actin. (C) 
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RPL4 enhances translation of other functional viral recoding sequences
Recoding also occurs in other contexts in the translation of viral proteins, i.e the -1 
frameshifting of the HIV-1 transcript; the HIV-1 sequence does not contain a pseudoknot, 
but forms a stem-loop downstream of the recoding site. The genome of the alphavirus 
Sindbis utilizes a leaky  termination sequence, a UGA stop codon followed by a cytidine, 
to control the ratio of its structural proteins. It has been believed that this stop codon and 
downstream base, termed the tetranucleotide code, was solely  responsible as the viral 
recoding sequence, without any contribution of a secondary structure (Li and Rice 1989; 
Li and Rice 1993). Recently it has been shown that in the context of the virus additional 
mRNA sequences promote readthrough to the levels necessary  for viral replication (Firth, 
Wills et al. 2011). However, for this work, we included only the leaky stop  codon 
sequence UGA C; the additional sequence contributions were not known at the time of 
the experiments. 
We tested RPL4 for effects on HIV-1 frameshift and the Sindbis readthrough sequences in 
our dual luciferase assay. The reporter plasmids for HIV-1 contain the slippery sequence 
and downstream 62 nucleotides containing the proposed extended stem loop  mRNA 
structure for the wild-type construct; the control disables the native slippery sequence to 
prevent frameshifting and adds an additional nucleotide to allow translation of the 
functional fluc reporter. The HIV-1 construct  showed about 6% frameshift efficiency. To 
test Sindbis readthrough we cloned a small fragment containing the UGA C 
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tetranucleotide code in the cloning site between the reading frames of the reporter; no 
other viral sequences were included, eliminating the possibility  of viral specific 
secondary  mRNA structure.  The control plasmid replaced the UGA stop  with CGA to 
allow maximum translation of the reporter. The UAG C tetranucleotide sequence 
promoted suppression of termination at a significant rate, about 3% of the time using our 
DLA reporter, which is comparable to the low end of MoMLV readthrough. 
Transfection of the RPL4 expression construct increased HIV-1 frameshift in a dose 
dependent manner similar to MoMLV readthrough, indicating that the effects of RPL4 
are not limited to suppression of termination, or dependent on a specific pseudoknot 
structure (Figure 3-19). Surprisingly, RPL4 also increased readthrough of the Sindbis 
recoding sequence when transfected at high levels. Since Sindbis recoding is not 
dependent on a secondary structure, the RPL4 effect may be due in part to an interaction 
that affects decoding or interferes with termination. 
 In an attempt to verify  whether the RPL4 enhancement of readthrough was related to the 
presence of a recoding sequence, rather than a general effect on termination, we tested 
mRPL4 in the DLA with a construct containing a scrambled pseudoknot (ScrPK) which 
retains the nucleotide composition of the native sequence but eliminates the predicted 
secondary  structure. However, raw values of this reporter construct were below the linear 
range of the DLA suggesting that the mRNA was not being translated at a significant 















































































































































































































































































































































































































































































































Figure 3-19. Effect of RPL4 on additional viral recoding sequences.                     
(A) Readthrough percentages of 293A cells co-transfected with dual luciferase 
reporters for HIV-1 frameshift, Sindbis readthrough, and ScrPK readthrough and 
increasing amounts of mRPL4, transfected in 96 well format. Readthrough levels from 
representative examples per reporter pair. Error bars correspond to standard error of 
averages of 3 wells. (B) Raw values of luciferase for MoMLV data in (A). (C) Raw 
values of luciferase for HIV-1 data in (A). (D) Raw values of luciferase for Sindbis data 





mediated decay (NMD) pathway. This idea is supported by recent work from our lab 
which correlates readthrough translation with increased mRNA stability (Hogg and Goff 
2010). Therefore the lack of the readthrough stimulating pseudoknot may  predispose the 
ScrPK reporter to nonsense-mediated decay at a rate that does not allow accumulation of 
substantial levels of luciferase. Even so, addition of mRPL4 to reactions containing 
ScrPK did not rescue readthrough to levels within linear range of the assay. 
RPL4 effect on readthrough of non-recoding premature stop codons is 
undetermined
The ScrPK construct we used as a no-pseudoknot control lacked the flanking sequences 
— the 13 base pairs before the stop codon, and the 6 nucleotides after the proposed end 
of the structure. Since it has been previously shown that the presence of the flanking 
sequences do have an effect on readthrough, we felt it was important to also test these 
sequences in our study of the RPL4 enhancement on readthrough, in case the leader 
peptide was playing a role. More importantly, in scrambling of the pseudoknot sequence, 
the nucleotide immediately following the stop codon was changed from a G to an A. This 
tetranucleotide sequence is known to have a profound effect on the incidence of 
readthrough; UAG A naturally  does not readthrough as frequently as UAG G (Fan-
Minogue and Bedwell 2007). Therefore, the decrease in readthrough we observed on the 
ScrPK sequence could be affected by  differences other than the lack of the secondary 
structure. We thus designed a new construct, 13ScrPK6 which retained the tetranucleotide 
stop codon sequence of the wildtype gag-pol junction, contained the 13 nucleotides 
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before the stop codon and 6 base paris after the putative 2nd stem of the pseudoknot, and 
had the scrambled nucleotide sequence of ScrPK. We transfected the new 13ScrPK 
sequence into 293A cells. However, the overall levels of the reporters were still too low 
to be interpretable (Figure 3-20).   The signal from firefly luciferase is inherently lower 
than Renilla, and an analysis of serial dilutions of Renilla and firefly luciferase shows 
that below total counts of 600 the assay is not linear (Figure 3-21).  Thus the assay can 
fail to register accurate levels of very  low readthrough, and an increase of a very low 
level remains unverifiable with these methods. 
We observed that the renilla levels with the stop codon containing ScrPK and 13ScrPK 
constructs were noticeably lower than the rluc with the corresponding 13PK6 construct. 
Low rluc levels, the denominator in our readthrough equation, result  in the appearance of 
very high readthrough.  Since rluc is placed before the pseudoknot in our reporters, 
renilla values give information on the general translation of the construct, indicating 
global cellular effects or specific attributes of the reporter. As with the ScrPK  reporter, 
we wondered whether the 13ScrPK6 construct  was more susceptible to NMD and if so, 
how we could assay  for the effect of RPL4 on a simple premature termination codon.  We 
thus attempted to reduce the effects of NMD by manipulating the cellular environment 
and also the reporter construct. 
UPF1 is an RNA binding protein that is involved in mRNA decay (Isken and Maquat 














































Figure 3-20.  Readthrough frequency of the 13ScrPK6 reporter. (A) Readthrough 
levels as determined by DLA of 13ScrPK6 reporter pair transfected into 293A cells in 6 























































Figure 3-21. Linear range of the dual luciferase assay. Serial two-fold dilution of 
in-vitro translation reaction with HIV-1 control construct. This construct has very high 
expression of firefly and Renilla luciferase. Lysates were diluted in passive lysis 
buffer. 
accumulation on mRNAs with a premature stop codon (PTC) seems, in many cases, to 
promote nonsense mediated decay. This is thought to be a sequence non-specific binding 
which is undisrupted by translation on mRNA’s with long 3’ UTR after the stop codon 
(Hogg and Goff 2010). We attempted to circumvent NMD effects on our no-pseudoknot 
containing reporter, which is a transcript containing a premature stop codon and should 
appear as an aberrant mRNA, by using dominant negative UPF1 mutants. 
We tested two UPf1 mutants, DD636AA and K498A (Kashima, Yamashita et al. 2006) 
with 13ScrPK6. We continued to see what looked like high levels of readthrough 
according to our calculation of ratios. However the raw values of the reporters again 
pointed to an anomaly; over-all levels of both were still low, and renilla in particular was 
lower (Figure 3-22).  UPF1 also interacts with the termination machinery, and the 
dominant negative forms may be preventing termination. This would result in a delay in 
translation as ribosomes would be unable to be efficiently  recycled, and a resultant 
decrease in total products. Therefore, we determined that interfering with the functions of 
UPF1 may have effects on multiple aspects of translations which would be impossible to 
interpret in our system. Additionally, our two reporter system is designed so the 
maximum readthrough is 100%, as normalized to normal translation; readthrough 
percentages about 100% should not be possible, as the fluc signal from the control 
reporter should signify maximum translation. 






















































































































































Figure 3-22. UPF1 dominant negative mutant effects on readthrough of 13ScrPK6.   
(A) Readthrough levels as determined by DLA of 1 ug 13ScrPK6 reporter pair co-
transfected with dominant negative UPF1 mutants in 293A cells in 6 well format. The 
13PK6 reporter pair was used as a positive transfection control. (B) Average raw values 
of luciferase for data in (A).
The RSE is an RNA sequence downstream of the gag stop codon, and is necessary for the 
stability  of the mRNA (Weil and Beemon 2006; Weil, Hadjithomas et al. 2009). Deletion 
or movement of this element more than 500 bp away from the gag stop codon results in 
decreased amounts of gag-pol mRNA. RSV utilizes a -1 framesift for the translation of 
gag-pol, much like HIV-1. However, the RSE is not  implicated in frameshift. The full-
length RSE is approximately 400 bps long, but a fragment of about 250 bp containing the 
3’ end (“C fragment”) has been shown to confer most of the protection against NMD. We 
cloned the C fragment into our 13ScrPK6 construct, after the scrambled pseudoknot and 
before the start of the fluc coding sequence. We transfected the 13ScrPK6_RSE 
constructs into 293A cells and performed the DLA. We again saw levels of rluc remained 
comparable with 13ScrPK6 (Figure 3-23), indicating the same amount of translation and/
or mRNA stability. However, the expression of fluc was markedly lower in the control 
reporter; fluc in the experimental (stop codon containing) reporter was still below the 
linear range of the assay.  The straight readthrough calculated from the raw numbers 
showed a higher level than 13PK6 or 13ScrPK6, but the raw values suggested that 
additional factors could be altering expression of the constructs. We surmised that the 
13ScrPK6 and RSE sequences could be translating a peptide moiety  that was interfering 
with the functionality of the luciferase reporters, and thus not an appropriate control.  
We thus decided to disregard the ScrPK containing constructs as proper controls for the 
presence of a recoding element. We designed a new dual luciferase reporter pair that 






























































Figure 3-23. Readthrough efficiency of 13ScrPK6_RSE reporter. (A) Readthrough 
levels as determined by DLA of 1 ug 13PK 6 or 13ScrPK6_RSE reporter pair 
transfected in 293A cells in 6 well format. (B) Average raw values of luciferase for 
data in (A).
CGA and extended the same length as the pseudoknot sequence. We replaced the CGA 
with a UAG to make an artificial PTC and designated this CollStop. The control plasmid 
contained the native sequence. We tested this construct  for expression of rluc and fluc. 
Levels of rluc were comparable to those of 13PK6 and 13PK6C, indicating a similar 
stability  and/or overall expression of the mRNA.  Fluc levels were also comparable for 
the control construct (Figure 3-24). The level of fluc in the experimental construct had a 
readthrough frequency of about 0.5%. Although fluc levels were in the 100s, still lower 
than the reliable limit of detection for the assay, the high rluc signal confirmed that this 
construct represented a context where NMD was not significant, and the lack of 
readthrough was a true event. 
We transfected the CollStop reporter pair in to 293A cells along with increasing amounts 
of mRPL4. In some trials, we observed slight increases in the levels of fluc (Figure 3-25). 
The levels were still below the linear range of the assay, but calculation of readthrough 
showed an increase in the presence of RPL4. Because this increase was not seen in all 
trials, and when present it  was still below the range of the assay, it is hard to interpret the 
actual effect of RPL4 on any  PTC or normal termination. However, the presence of a 
recoding stimulus  appears to enhance the effect of RPL4. 
PseudoKnot mutants and RPL4
Our lab has previously tested RPL4 on various pseudoknot mutants with impaired 






































































Figure 3-24. Comparison of readthrough efficiency of reporter constructs.                  
(A) Readthrough levels as determined by DLA of 1 ug 13PK6, 13ScrPK6_RSE, or 
CollStop reporter pairs transfected in 293A cells in 6 well format. Graph shows 
representative experiment. Error bars correspond to standard deviation of averages 


















































































































































































Figure 3-25. RPL4 effects on Collstop readthrough. (A) Readthrough based on dual 
luciferase assay results of 13PK6 or CollStop reporter pair co-transfected with 1, 3, or 6 
ug of mRPL4 in 293A cells in 6 well format. Graph shows representative experiment. 
Error bars correspond to standard deviation of averages derived from triplicate readings 
of cell lysates. (B) Average raw values of luciferase for data in (A).
(Figure 3-26). These constructs contain point mutations within pseudoknot sequence 
which have been shown to alter the normal frequency of readthrough, presumably by 
changing the stability  of the pseudoknot structure or the ability of ribosomal or other host 
factors to interact with the viral mRNA. We also tested a pair of pseudoknot mutants. 
U38C has been shown to be hypoactive: this point mutation results in reduced 
readthrough; changing the same base to an A gives a hyperactive mutant  (Alam, Wills et 
al. 1999).  Again, mRPL4 was not able to increase readthrough for the hypoactive mutant 
(Figure 3-27), in agreement with earlier experiments, although the same considerations of 
mRNA stability as the ScrPK are applicable given the raw luciferase levels.  RPL4 
enhanced the readthrough of the hyperactive pseudoknot mutant U38A about 2 fold, 
which is comparable to its effects on the wildtype sequence (Figure 3-27).   Therefore, 
RPL4 does not rescue readthrough of a non-functional recoding signal, but is able to 
enhance the readthrough frequency of a more efficient pseudoknot. 
RPL4 increases readthrough at all three stop codons
Previous studies on the MoMLV gag-pol junction showed that readthrough could occur 
with any of the three stop  codons (Feng, Levin et al. 1989). We tested the RPL4 effect on 
pseudoknot-containing sequences containing the UGA and UAA stop  codons. We 
transfected 293A cells with dual luciferase constructs containing the alternate stop codons 
in front of the MoMLV pseudoknot sequence, with and without RPL4. We observed that 
































































Figure 3-26. Effects of RPL4 on MoMLV pseudoknot mutants. Only the double 
compensatory mutant G15&16C:C25&26G compensatory mutant, which retains near 
wild-type readthrough activity, shows an RPL4 dependent enhancement of readthrough. 

















































































































































































































































































































































































































































































































Figure 3-27. Effects of RPL4 on hyperactive pseudoknot mutant. (A) Readthrough 
levels based on dual luciferase assay of U38C hypo - and U38A hyper-active MoMLV 
pseudoknot mutants co-transfected with increasing levels of mRPL4 in in 293A cells 
in 6 well format. Graph is from representation experiment.  Error bars correspond to 
standard deviation of averages derived from triplicate readings of cells lysates. (B) 
Average raw values of luciferase for data in (A). 
Pseudoknot mutant and RPL4




































































































Figure 3-28. RPL4 enhancement of readthrough of alternate stop codons. (A) 
Readthrough from dual luciferase assay of 13PK6 reporter pair with UAG, UGA or 
UAA stop codon co-transfected with 6 ug of mRPL4 in 293A cells in 6 well format. (B) 
Fold change of readthrough (RPL4 overexpression levels/reporter alone) for data in (A). 







The UAA stop  codon containing construct showed the least amount of basal readthrough. 
This result corresponds with the findings of PTC in other transcripts. UAA is known to be 
most resistant to readthrough in general, even with the addition of readthrough promoting 
drugs (Fan-Minogue and Bedwell 2007). Interestingly, although the level of RPL4 
induced readthrough was only 2% percent with UAA, as opposed to 1% percent without 
RPL4, the fold increase was actually  higher than the RPL4 enhancement of UGA- and 
UAG-containing transcripts in these trials. RPL4 may  affect readthrough by a different 
mechanism than the one that allows differential suppression of termination of  the three 
stop codons. 
RPL4  does not enhance readthrough in in-vitro translation reactions
In an attempt to further characterize the RPL4 effect, and to clarify the role of the RPL4 
protein (as opposed to the RNA or some other effect) we attempted to co-express RPL4 
and the dual luciferase reporters in a rabbit reticulocyte lysate in-vitro translation (IVT) 
system. We initially employed an in-vitro translation system only  using mRNAs for the 
dual luciferase reporters, mRPL4 and S3a that were produced in separate transcription 
reactions using T7 polymerase. These mRNAs were then added to the IVT lysates for 
translation. No increase in readthrough was evident with the addition of RPL4 mRNA. 
Because some mRNAs are highly labile, we thought perhaps there was degradation of 
RPL4 mRNA, which would diminish its translation and subsequently diminish the RPL4 
effect. We switched to a transcription and translation (TnT) system; in this system 
transcription of mRNA by T7 polymerase occurs in the same reaction tube as translation. 
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cDNA is added directly  to the reaction, and the issues of mRNA stability  and purity are 
bypassed. We observed a small increase in readthrough with the addition of any cDNA; 
increase in readthrough was not unique to RPL4 (Figure 3-29). We concluded that there 
must be an active competition for transcription and translation machinery in these 
reactions, and that we were not getting adequate levels of RPL4 to have an effect. We 
then pre-translated RPL4, by  adding the RPL4 cDNA alone for 30 minutes before the 
addition of the dual luciferase reporter constructs. We still did not observe a significant, 
specific increase in readthrough attributable to RPL4 (figure 3-30). 
We next attempted to add the RPL4 protein directly to the IVT reaction. We expressed 
GST-tagged RPL4 and S3a in bacteria, purified the proteins on a glutathione column, and 
added the tagged protein directly to the IVT lysate. We did not observe an increase in 
readthrough with either RPL4 or S3a (Figure 3-31). Since our N-terminal flag tagged 
RPL4 and N-terminal truncation mutants of RPL4 did not enhance readthrough we 
concluded that the tag might be interfering with the function of RPL4 in the IVT system. 
We attempted to cleave the GST tag with thrombin. RPL4 could not  be recovered from 
this procedure, although we were able to recover S3a, as viewed by  Coomassie staining 
of the recovered recombinant protein. Therefore, we were unable to produce a stable, 
soluble untagged version of RPL4 to test in the IVT system. These difficulties prevented 
further use of the IVT system,  as there appears to be a  block to the RPL4 effect in the 
reconstituted translation mix. This could include a saturation of a readthrough-prohibiting 



























































Figure 3-29. RPL4 effect on readthrough in TnT IVT reaction.  (A) Readthrough 
based from dual luciferase assay  of 0.25 ug of 13PK6 reporter pair transcribed and 
translated with 1 ug RPL4, RPL4-FS, or RPL22 in in-vitro transcription and translation 
reaction. Results shown from representative experiment,  error bars correspond to 
standard deviation of averages derived from triplicate readings of each IVT reaction. 






































































Figure 3-30. Effect of pre-translated RPL4 on MoMLV readthrough in TnT IVT 
reaction. (A) Readthrough based on dual luciferase assay results of 1 0.25 ug of 
13PK6 reporter pair transcribed and translated with RPL4 or RPS3a  in in-vitro 
transcription and translation reaction. 1 ug cDNA for RPL4 or RPS3a was added to 
TnT IVT reactions 30 minutes before reporter DNA.  Graph is of representative 
experiment,  error bars correspond to standard deviation of averages derived from 




































































































































Figure 3-31. Effect of RPL4-GST tagged protein on readthrough in TnT IVT 
reaction. (A) Readthrough based on dual luciferase assay results of 1 0.25 ug of 13PK6 
reporter pair transcribed and translated with 0.5 ug, 1.0 ug, or 2.0 ug GST-tagged RPL4 
or RPS3a protein in in-vitro transcription and translation reaction. Graph is of 
representative experiment,  error bars correspond to standard deviation of averages 
derived from triplicate readings of each IVT reaction. (B) Average raw values of 
luciferase for data in (A).
Release factor over-expression negates RPL4 enhanced readthrough
We next examined the effect  of over-expression of termination factors on readthrough. 
Our lab has previously discovered an interaction between reverse-transcriptase and eRF1 
(Orlova, Yueh et al. 2003). Reverse transcriptase can bind eRF1, perhaps to sequester it 
and allow readthrough to occur.  Additionally, overexpression of eRF1 reversed the 
increase in readthrough which resulted from overexpression of reverse transcriptase. 
Concurrent with our RPL4 work, we immuno-depleted eRF1 from IVT lysates as a step 
in customizing translation mixes for a cryo-EM visualization of the pseudoknot on the 
ribosome, described in the appendix (Figure A-10). We observed an increase in 
readthrough, and in frameshift, in lysates with reduced eRF1. 
We transfected 293A cells with cDNAs for eRF1 and eRF3 and the 13PK6 reporter pair. 
We performed western blot analysis to verify over-expression and saw only  slight 
increases in levels. Since eRF1 and eRF3 are well conserved among mammals, a high 
affinity specific antibody is likely hard to produce. There also may be regulatory 
elements that control the levels of termination factors in cells, similar to what we 
hypothesize for RPL4. Surprisingly, we saw no decrease in readthrough in the dual 
luciferase assay, with transfection of eRF1 or eRF3 separately or together (Figure 3-32). 
However, when we performed a series of assays with RPL4 and eRF1 and eRF3, we saw 
that expression of the termination factors could abrogate the RPL4 increase in 
readthrough (Figure 3-33).  As a control we tested a combination of RPL4 with RPL7, 









































































































Figure 3-32. Release factor effect on MoMLV readthrough. (A) Readthrough 
percentages based on dual luciferase assay results of the 13PK6 reporter pairs co-
transfected with 1, 3, or 6 ug of eRF1 and/or eRF3 in 293A cells in 6 well format. 
Graph is of representative experiment,  error bars correspond to standard deviation of 
averages derived from triplicate readings of each transfection mix. (B) Average raw 
































































































Figure 3-33. Combined effects of Release Factor and RPL4 on MoMLV 
readthrough. (A) Readthrough percentages based on dual luciferase assay results of 
the 13PK6 reporter pairs co-transfected with 6 ug RPL4 and/or 3 ug of eRF1 and eRF3 
in 293A cells in 6 well format. Graph is of representative experiment,  error bars 
correspond to standard deviation of averages derived from triplicate readings of each 
transfection mix. (B) Average raw values of luciferase for data in (A).  
RPL4 did not reduce readthrough; rather readthrough levels remained constant (Figure 
3-34). 
eRF1 has been shown to be able to cause termination by itself, although at a slower rate 
than when eRF3 is present (Alkalaeva, Pisarev et al. 2006). We surmised that eRF1 was 
the key component in the abatement of RPL4’s effect on readthrough. We saw that 
indeed, by itself, eRF1 had the ability to reduce the RPL4 enhancement of readthrough. 
Increasing the ratio of RPL4 to eRF1 lessened the eRF1 effect; when equal amounts of 
the constructs are transfected together, the reduction of readthrough is most pronounced 
(Figure 3-35). 
RPL4 and G418 act additively to increase MoMLV readthrough
Concurrent work, described in the next chapter, investigates the effects of readthrough 
promoting drugs on the gag-pol ratio. G418 is a widely used aminoglycoside which 
induces miscoding and suppression of termination in bacteria (reviewed in (Houghton, 
Green et al. 2010). It has been shown that many aminoglycosides bind to rRNA in the 
decoding center, and force a conformation which allows non-cognate interactions to be 
tolerated. Derivatives of G418 are used to treat human diseases that result from premature 
stop codons; readthrough events allow production of otherwise truncated proteins. 
Treatment of cells with G418 increased MoMLV readthrough in a dose dependent 
manner (Figures 3-36 and 4-4, discussed in detail in Chapter 4). We were curious whether 


































































































































Figure 3-34.  Combined effects of RPL4 and RPL7 on MoMLV readthrough.  (A) 
Readthrough percentages based on dual luciferase assay results of the 13PK6 reporter 
pairs co-transfected with increasing amounts of RPL4 and RPL7 alone and together in 
293A cells in 96 well format. Graph is of representative experiment, error bars 
correspond to standard deviation of averages derived from triplicate readings of each 




















































































































































































eRF1 and RPL4 transfection mix
A
B
Figure 3-35. eRF1 effects on RPL4 enhancement of readthrough. 
(A) Readthrough percentages based on dual luciferase assay results of the 13PK6 
reporter pairs co-transfected with increasing amounts of RPL4 and eRF1 alone and 
together in 293A cells in 96 well format. Graph is of representative experiment, error 
bars correspond to standard deviation of averages derived from triplicate readings of 
each condition. (B) Average raw values of luciferase for data in (A).
RPL4 in manipulation of the decoding center similar to that of an aminoglycoside. 
We transfected RPL4 and the 13PK6 reporter pair into 293A cells, and added G418. We 
saw that G418 and RPL4 worked in an additive manner. The readthrough was higher in 
cells with RPL4 and exposed to G418 at  over 4 fold (Figure 3-36). The result was slightly 
higher than the combination of both RPL4 and G418 alone, but  not an exponential 
increase that would suggest a synergistic effect. It  appears that RPL4 and G418 do not 
function on the same site to alter decoding.  If RPL4 simply perturbs the decoding site 
out of the restrictive conformation, it would be expected that G418 would have no 
additional effect. Therefore, RPL4 may  function at another point in the proofreading 
process.
RPL4  enhancement of readthrough is not due to ribosome biogenesis
In an effort to further elucidate the nature of RPL4 enhancement of readthrough we 
attempted to analyze whether transfection of RPL4 cDNA was stimulating ribosome 
biogenesis.  RPL4 has a role in the processing of rRNA, and is perhaps a trigger for 
ribosome biogenesis (Egoh, Nosuke Kanesashi et al. 2010), and therefore it is plausible 
that in our system we were triggering an up-regulation of ribosome biogenesis. 
Depending on the stoichiometry of ribosomes to termination machinery, an increase in 
ribosome number could deplete the available pool of termination factors, thus allowing 




























































































Figure 3-36. Effects of G418 and combined G418/RPL4 on readthrough              
(A) Fold increase of readthrough percentages from dual luciferase assay of the 13PK6 
reporter pairs transfected in 293A cells treated with G418, in 6 well format.               
(B) Readthrough percentages from dual luciferase assay of the 13PK6 reporter pairs 
transfected with 9 ug of RPL4 and/or 1 mg/ml G418 in 293A cells in 6 well format. 
Graphs are of representative experiments, error bars correspond to standard deviation 
of averages derived from triplicate readings of each transfection mix. (C) Average raw 






















































We also theorized that the cell line dependence of the RPL4 effect could be used to 
determine what was causing the increase in readthrough in some cells. If ribosome 
biogenesis was being triggered by  transfection of RPL4 cDNA, perhaps responding cells 
had a different basal level of ribosomes than non-responding cells. We first  attempted to 
quantify the level of endogenous RPL4 in a sampling of responding and non-responding 
cell lines. We picked 293A and 293T  for responding cells, and  A549 and TE671 as non-
responders. Our intention was to expand our test  to include all the cell lines surveyed if 
we found anything of interest in a smaller pool. 
We verified that the RPL4 monoclonal antibody  A43 would detect human and rodent 
RPL4 (Figure 3-37) by testing its ability  to detect GST-tagged RPL4 we had made for in-
vitro translation and endogenous RPL4 in 293A and NIH3T3 cells. We observed an 
increase in signal with increase in total protein loaded, but differences of two fold were 
hard to distinguish. We lysed 500,000 cells (80% confluency) of each cell type in RIPA 
buffer, quantitated protein concentration using the Bradford assay, and loaded equal 
amounts of total protein per sample. We analyzed the lysates via Western blot with the 
RPL4 monoclonal antibody A43.  We could see no distinguishable variation in the 
amount of RPL4 in responding and non-responding cells (Figure 3-38). Therefore we 
could not conclude that differences in endogenous levels of RPL4 were responsible for 
the cell line dependence of the RPL4 effect, as a catalyst  for ribosomal biogenesis. We 
also transfected the same panel of cells with 6 ug of mRPL4 cDNA and performed WB 





















Figure 3-37.  Monoclonal antibody detection of endogenous mouse and human 
RPL4. (A) Commassie stained gel of GST-tagged RPL4 protein. (B) Western blot of 
GST-tagged RPL4 protein, probed with monoclonal antibody to RPL4. (C) Western 
blot of endogenous mouse RPL4 in NIH3T3 cells. Lysates were loaded in decreasing 
concentrations to determine if differences in RPL4 levels could be detected. (D) 
Western blot of endogenous human RPL4 in 293A cells. Lysates were loaded in 








RPL4 responsive RPL4 non-responsive
Figure 3-38: Levels of endogenous RPL4 in responsive and non-responsive cells. 
Western blot of endogenous RPL4 in 293A, 293T, Te671 and A549 cells, probed with 
monoclonal anti-RPL4 and and anti-tubulin as a loading control. 
expression between endogenous and transfected cells (Figure 3-39). 
We examined the expression of the ribosomal protein RPL10a as an additional indicator 
of ribosome number. L10a is component of the large subunit with no known extra-
ribosomal or cytoplasmic function, and therefore increase in the amount of RPL10a 
would be attributable to an increase in ribosome number. We again transfected the 6 cell 
lines with 6 ug of RPL4, and performed WB analysis on endogenous and transfected 
samples. We saw no increase in L10a among any of the cell lines (Figure 3-40).  
We then attempted to use qPCR methods to quantitate ribosomes. Translation could only 
be affected by  an increase in 80S ribosomes, which could be measured by  28S rRNA via 
qPCR. We transfected the same cell lines with 6 ug of mRPL4 cDNA and extracted RNA 
24 h post transfection. We made cDNA pools from each cell type and performed qPCR 
using primers against 28S rRNA, with actin as a control. We saw slight increases in 28S 
rRNA amounts in cells transfected with RPL4, which could indicate an increase in 
ribosomes. However, this result  was consistent among all the cell types; thus ribosome 
biogenesis was not the singular factor in dictating the response to RPL4 or the RPL4 
enhancement of readthrough (Figure 3-41).
RPL4 increase in gag-pol readthrough has deleterious effects on viral replication
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RPL4 responsive RPL4 non-responsive
Tubulin
RPL4
Figure 3-39: RPL4 overexpression in responsive and non-responsive cell lines. 
Western blot of  RPL4 in 293A, 293T, Te671 and A549 cells, probed with monoclonal 
anti-RPL4 and and anti-tubulin as a loading control. O/E lysates were transfected with 
6 ug mRPL4 in 6 well format.
137
Figure 3-40.   Figure 2-40. RPL4 overexpression effects on RPL10a expression. 
Western blot of RPL10a in 293A, 293T, Te671 and A549 cells, probed with monoclonal 
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Figure 3-41. Effects of RPL4 overexpression on 28S rRNA in responsive and non-
responsive cells. Results of qPCR of 28S rRNA levels in cells transfected with 6 ug 
RPL4 in 6 well format. Endogenous levels refer to untransfected cells. 28S rRNA 
levels were normalized to actin mRNA levels. Graph is from representative 
experiment.
MoMLV in vivo. We transfected 293T cells with the pNCS MoMLV provirus, and 
increasing amounts of mRPL4 or S3a. Cells were lysed 48 hours post transfection and 
blotted using the anti-capsid antibody R187. In lysates from all cells transfected, the gag 
precursor Pr65gag could be detected at consistent  levels, whereas the gag-pol fusion 
product Pro200gag-pol was undetectable.  However, lysates from cells transfected with 
RPL4 exhibited a dose-dependent decrease in processed capsid, even as Pr65gag  precursor 
levels appear unchanged (Figure 3-42). The reduced defect in processing is likely  a result 
of alterations to viral assembly; increased readthrough alters the gag:gag-pol ratio and 
this is thought to affect the stoichiometry and formation of the virus. Cells transfected 
with increasing levels S3a show no change in processed capsid levels compared to basal 
levels  in the virus only control. 
To monitor viral release, we harvested virus released from producer cells 48 hours after 
transfection. We pelleted virus from the filtered culture media of cells transfected with 
RPL4 and RPS3a and analyzed the collected virus for capsid protein via western blot. In 
supernatants from cells co-transfected with RPL4 there is a strong dose dependent 
reduction in capsid levels, indicating inhibition of viral formation and/or release. There 
was no change in the amount of capsid detected in virus produced with RPS3a 
overexpression. Therefore, the RPL4 enhancement of readthrough has a negative effect 
on viral production through alteration of the gag:gag-pol ratio, affecting both assembly 
















































































































































Figure 3-42: Effects of RPL4 on viral replication. (A) Western blot of lysates of 
293T cells transfected with 1 ug pNCS and 1ug, 3 ug or 5 ug RPL4, probed with anti-
capsid antibody and anti-actin as a loading control. (B) Western blot of lysates of 293T 
cells transfected with 1 ug pNCS and 1ug, 3 ug or 5 ug RPS3a, probed with anti-capsid 
antibody and anti-actin as a loading control.  (C) Western blot of viral pellets collected 
from culture media of 293T cells transfected with 1 ug pNCS and 1ug, 3 ug or 5 ug 
RPL4, probed with anti-capsid antibody. (D) Western blot of viral pellets collected from 
culture media of 293T cells transfected with 1 ug pNCS and 1ug, 3 ug or 5 ug RPS3a, 







Chapter 4: Readthrough Promoting Drugs and Retroviral Recoding
Aminogylcoside antibiotics have been traditionally used to treat bacterial infections due 
to their effects on prokaryotic translation. Aminoglycosides are highly positively charged 
molecules that  are naturally  produced by certain microorganisms. They  are medically 
classified as amino-modified sugars (MeSH), and share a basic structure of a 2-
deoxystreptamine (ring II) linked to a glucopyranosyl ring (ring I) (Figure 4-1). 
Aminoglycosides are poorly taken up  by eukaryotic cells as they do not easily diffuse 
across the cell membrane. Bacterial cells possess transporters that actively take up 
aminoglycosides, and this may be a partial cause for the increased toxicity and effect on 
miscoding in prokaryotic cells (Houghton, Green et al. 2010). 
Aminoglycosides promote miscoding by interacting with the rRNA of the decoding 
center and causing changes in the rRNA conformations that allow for incorporation of 
near and non-cognate amino acids. This alteration to the proofreading machinery of the 
ribosome also permits readthrough of stop  codons. The family of aminoglycosides is 
large, but subtle variations in structure determine efficacy and toxicity. These variations 
consist of oxygen or nitrogen at the 6’ position of ring 1 and additional sugars attached to 
ring II (Figure 4-2) (Fan-Minogue and Bedwell 2007). Most aminoglycosides have a 
greater affinity for the prokaryotic decoding center and this difference allows for their use 





Figure 4-2. Substitutions and variations in aminoglycoside structure. Structures of 
(A) G418, (B) paromomycin and (C) neomycin. Relevant differences between G418 and 
paromomycin at the 6’ position of Ring 1 circled in green. Neomycin shares the same 
linkage to Ring II and additional structure with paromomycin (circled in orange), but is 






Crystal structures of bacterial 30S subunits and aminoglycosides demonstrate the 
interactions that result in miscoding. Paromomycin has been modeled in complex with 
the bacterial rRNA; the drug binds the 16S rRNA at helix 44. The region of rRNA 
contains the proofreading nucleotides A1492 and 1493 and the bound drug displaces their 
native positions (Figure 4-3). This change in orientation allows acceptance of near and 
non-cognate tRNAs and results in incorporation of alternate amino acids. The 
parmomoycin-induced change in conformation is not identical to the shift that occurs 
upon cognate interactions, suggesting that the default inhibitory  conformation is the 
defining factor in selection. 
 In addition to their use in combating bacterial infections, aminoglycosides are used to 
treat human diseases caused by premature termination codon mutations. Duchennes 
muscular dystrophy and cystic fibrosis are caused by  nonsense mutations in coding 
sequences that  cause inappropriate termination at premature stop codons and produce 
truncated dysfunctional proteins (reviewed in (Hermann 2007)). Treatment with 
aminoglycosides provides readthrough at a frequency  which allows enough translation of 
the full-length protein to restore normal function. However, at  high enough doses, 
aminoglycosides cause defects in eukaryotic translation and this dosage effect allows for 
their use in selection in tissue culture.  We examined the effects of aminoglycosides on 
eukaryotic recoding in the context of retroviral readthrough.
144
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Figure 4‐3: Paromomycin bound to 16S RNA. (A) The key decoding 
center nucleotides (green) in an A-site-vacant 30S ribosome subunit. (B) The 
key decoding nucleotides undergo conformational changes when the 30S 
subunit binds a cognate anticodon stem loop (ASL, yellow). Adenosine 1492 
(A1492) and A1493 are displaced from helix 44 of the 16S rRNA to a 
position where they can engage the minor groove of the codon-anticodon 
helix in the A-site. (C) Paromomycin (orange) –binding of the 30S subunit 
induces similar conformational changes in the key residues. (D) The RF1 
(yellow) -bound 70S ribosome structure shows a different conformational 
change where only A1492 unstacks from helix 44 and A1493 remains 
stacked within the helix. This positioning of A1493 is stabilized by the 
movement of A1913 of the 23S rRNA (brick red) into the region to provide a 
stacking interaction.  Reprinted from Cell, Vol. 136, Issue 4,  Zaher and 
Green, Fidelity at the Molecular Level: Lessons from Protein Synthesis, pp. 
746-762, 2009,with permission from Elsevier. 
Aminoglycosides increase MoMLV readthrough in Vivo
G418 is a drug widely  used in cell selection and we tested its effects on readthrough of 
MoMLV gag-pol. We transfected 293A cells with the 13PK6 reporter pair. Two hours 
later we replaced the media with media containing increasing doses of G418. We 
harvested the cells 24 hours after adding the drug, and analyzed readthrough with the 
dual luciferase assay. G418 treatment results in dose dependent  increase in readthrough 
(Figure 4-4).  Readthrough was increased from the normal basal level of 3-5% to greater 
than 11% with the highest dose of 2 mg/ml.  This concentration is often used for cell 
selections, and the levels of raw luciferase show that overall translation is inhibited. 
Lower levels of drug also result in an increase in readthrough. Thus, G418 does increase 
MoMLV pseudoknot controlled readthrough. 
We next tested G418 in a transducing virus assay  to determine whether the increase in 
readthrough we saw with the DLA reporters would affect viral replication.  We 
transfected 293T cells with plasmids encoding components for recombinant MoMLV. We 
used a 3 plasmid system consisting of expression constructs for MoMLV gag-pol, VSV-G 
envelope and an MoMLV-based vector with the MoMLV packaging signal and LTRs 
expressing the firefly luciferase gene. This mix produces a recombinant virus that is 
assembled with MoMLV gag and pol products and an envelope that will allow infection 
of many cell types. The recombinant virus genome carries only  the firefly luciferase 




















































































































Figure 4-4. G418 effects on MoMLV readthrough in 293A cells.  (A) Readthrough 
percentages based on dual luciferase assay results of the 13PK6 reporter pair 
transfected in 293A cells in 6 well format. G418 was added in increasing amounts. 
Graph is of representative experiment, error bars correspond to standard deviation of 
averages derived from triplicate readings of each transfection mix. (B) Average raw 
values of luciferase for data in (A).
function as a reporter of infectivity. We also transfected a separate plasmid encoding 
Renilla luciferase (rluc) as a control for general translational health in the producer cells. 
Two hours after transfection, we replaced the transfection media with media containing 
G418 at increasing concentrations. Twenty-four hours post drug treatment we collected 
virus from the supernatant, and infected naïve 293A cells. Forty-eight hours later we 
lysed the infected cells and performed a luciferase assay  to measure expression of fluc as 
an indicator of viral production and infectivity. We also measured the rluc in the producer 
cells to determine if the drugs were having an impact on general translation at the levels 
used. Cells infected with virus from G418 treated producer cells had lower fluc signals, 
indicating that less virus was produced, or that there were defects in packaging of the fluc 
gene and assembly of virus due to improper ratios of gag-pol (Figure 4-5). The rluc 
signals from producer cells also decreased with increases in G418 concentration, 
indicating an overall defect in translation from the toxicity of the drug.
We performed a viability assay with G418 using PrestoBlue live cell imaging reagent. We 
transfected 293A cells with 13PK6 and control. Two hours post  transfection we replaced 
the transfection media with G418 containing media in increasing concentrations. We also 
treated a separate plate of 293A cells with same G418 mixes to test cell viability. Twenty-
four hours post drug addition we assayed for dual luciferase and cell viability. G418 
greatly reduced cell viability  at concentrations that resulted in highest readthrough 
(Figure 4-6). Therefore, it is difficult to determine whether it was a reduction in the 




















































































Figure 4-5. G418 effects on viral production: transducing virus assay.             
(A) Fluc levels in naive 293A cells infected with recombinant virus produced in 
































































































Figure 4-6. G418 effects on cell viability and readthrough. Readthrough percentages 
based on dual luciferase assay results of the 13PK6 reporter pair transfected in 293A 
cells in 6 well format. G418 was added in increasing amounts 2 hours after transfection. 
Cell viability was measured with PrestoBlue reagent added to non-transfected cells 
exposed to the same G418 media. 
expression of the fluc reporter measured in the transducing virus assay. 
We tested additional aminoglycosides, and the small molecule PTC124 (Hirawat, Welch 
et al. 2007; Welch, Barton et al. 2007; Du, Liu et  al. 2008) in similar experiments. We 
transfected 293A cells with the 13PK6 reporter pair and 2 hours post transfection, 
replaced the transfection media with media containing drugs. G418, PTC124, 
paromomycin, amikacin and gentamicin all increased readthrough (Figure 4-7).  The 
average fold increase from at least three trials of each concentration is shown in (Figure 
4-8.)  Paromomycin has an ~ 2.5 fold effect on readthrough at high concentrations. 
PTC124 treatment results in a twofold increase in readthrough. Gentamicin, a derivative 
of G418, also modestly increases readthrough at doses suggested for cell selection. 
Amikacin, also used in eukaryotic cells, did not increase readthrough. Paromomycin and 
amikacin are used to treat infections in mammals and are well tolerated by eukaryotic 
cells, as the rluc levels of the reporter demonstrate. PTC124 and gentamicin are also used 
therapeutically, and do not cause the defects in translation that G418 does. Thus, a 
moderate amount of readthrough increase can be induced by aminoglycosides in vivo 
without significant cell death. 
We tested Hygromycin, which works by inhibiting racheting of the ribosome and tRNA 
movement instead of interacting with the decoding center. Hygromycin was extremely 





































































































































































































































































Figure 4-7. Readthrough promoting drug effects on MoMLV readthrough.               
(A) Readthrough percentages based on dual luciferase assay results of the 13PK6 reporter 
pair transfected in 293A cells in 6 well format. Drugs were added in indicated amounts 
two hours after transfection. Graph is of representative experiment, error bars correspond 
to standard deviation of averages derived from triplicate readings of each transfection 












































































































































Figure 4-8. Readthrough promoting drug effects on MoMLV readthrough.            
Fold changes in readthrough of the 13PK6 reporter in 293A cells treated with 
aminoglycosides or PTC124. Graph shows results of 2-4 trials per condition, error bars 
correspond to standard deviation of the mean of average fold changes per condition. 
toxic to use as well. Kanamycin did not give any increase in readthrough. Since we 
routinely use the aminoglycoside streptomycin in our cell culture media, we also tested 
its effect on readthrough. We saw no increase in readthrough at doses of streptomycin at 
and above standard tissue culture concentrations (Figure 4-9). 
Readthrough promoting drugs can affect retroviral replication
G418 affects retroviral replication
We looked at the effect  of these drugs on viral production with a transduction assay 
(Figure 4-10), following the protocol described previously. G418 had the most profound 
effect on viral production, as measured by firefly  luciferase levels. At the highest 
concentrations (2 mg/ml and 1mg/ml), G418 reduced signals of firefly luciferase by up  to 
3 logs in the infected cells, compared to the no drug control (Figure 4-11). However, 
renilla luciferase levels in the producer cells were reduced correspondingly (Figure 4-12), 
indicating that the high levels of G418 were impeding normal translation, as we observed 
in previous experiments. At lower levels, G418 had a more modest effect on the levels of 
fluc in infected cells, and had a correspondingly milder effect on translation as measured 
by rluc.  Therefore, cell death is likely a contributing factor to the reduction in viral 
production.  However the DLA results of the same concentrations show increased levels 
of readthrough, providing evidence that the disruption of the gag-pol ratio is also a 











































































































































































Figure 4-9. Streptomycin effects on MoMLV readthrough.                                        
(A) Readthrough percentages based on dual luciferase assay results of the 13PK6 reporter 
pair transfected in 293A cells in 6 well format in media +/- penicillin/streptomycin. 
Graph is of representative experiment, error bars correspond to standard deviation of 
averages derived from triplicate readings of each transfection mix. (B) Readthrough 
percentages based on dual luciferase assay results of the 13PK6 reporter pair transfected 
in 293A cells in 6 well format. Drugs were added in indicated amounts two hours after 
























Figure 4-10. Drug effects on viral replication: transducing virus assay. Fluc levels 
in naive 293A cells infected with virus produced in cells treated with aminoglycosides 
or G418. Ratios on x-axis refer to dilutions of virus based on neat concentration of 


























Figure 4-11: Drug effects on viral replication: transducing virus assay. Detail of 
firefly luciferase levels in infected cells from virus produced in cells treated with drugs, 



























Figure 4-12: Drug effects on viral replication: transducing virus assay. Renilla 
luciferase levels in 293A producer cells treated with drugs; an rluc expressing plasmid 
was co-transfected with the recombinant virus mix to measure drug effects on overall 
translation. 
PTC124  decreases retroviral replication
PTC124 treatment of virus-producing cells reduced the amount of firefly luciferase in 
infected cells by more than half, suggesting that the increase in readthrough of gag-pol 
had a deleterious effect on viral production. In the DLA PTC124 caused a higher increase 
in readthrough than G418; therefore, we expected that the effect on viral production 
would be greater than G418.  PTC124 also slightly  reduced rluc expression in producer 
cells, despite its relative non-toxicity in cells. There is a controversy  concerning PTC124 
and its interaction with firefly luciferase; it has been reported that PTC124 can bind to 
firefly luciferase and increase its stability, which in turns skews the readthrough ratio 
(Auld, Thorne et  al. 2009; Peltz, Welch et al. 2009; Auld, Lovell et al. 2010) Therefore, 
an increase in firefly  signal could be due to drug-firefly luciferase interactions rather than 
a reduction of the amount of firefly luciferase produced. Although PTC 124 treated cells 
may  show an artificially elevated fluc signal due to the drug:luciferase interaction, in this 
context, fluc measures infectivity of naive cells that should not be affected by PTC124. 
Amikacin does not significantly affect retroviral replication
Cells infected with virus produced in the presence of amikacin had slightly lower levels 
of firefly  expression. Rluc expression was only slightly  reduced in producer cells, 
indicating no gross effects on translation. Amikacin is used therapeutically, and therefore 
toxicity was not expected to be extreme. 
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Paromomycin decreases retroviral replication
Cells infected with virus produced in paromomycin treated cells had lower firefly 
luciferase levels, with signals decreasing by almost a log. Producer cells showed the least 
change in Renilla luciferase expression compared with the no-drug control. 
Paromomycin is also used therapeutically, and does not seem to impair overall 
translation. 
Aminoglycosides and PTC124 increase Sindbis/Leaky stop codon readthrough in 
vivo
We tested the effects of the amino-glycoside dirges on the Sindbis/Leaky stop  codon dual 
luciferase reporter to compare with the MoMLV readthrough results, and to corroborate 
our findings with previously published data (Fan-Minogue and Bedwell 2007). We 
repeated our transfection and drug treatment of 293A cells with the Sindbis “UGA C” 
reporter pair and examined readthrough with the DLA in the presence of the 
aminoglycosides. We adjusted the levels of G418 to only include the lowest 
concentrations to minimize the toxic effects. In cells treated with G418, readthrough was 
higher than the comparable 13PK6 results (Figure 4-13). PTC124, paromomycin and 
gentamicin treated cells had modestly  greater increases in readthrough of the UGA C stop 
codon than the comparable MoMLV pseudoknot containing 13PK6. These results are in 
agreement with studies on the variance in effect of aminoglycosides on different stop 

























































































































































































































Figure 4-13: Drugs effects on Sindbis leaky stop codon readthrough.                      
(A) Readthrough percentages based on dual luciferase assay results of the Sindbis 
reporter pair transfected in 293A cells in 6 well format. Drugs were added in indicated 
amounts two hours after transfection. Graph is of representative experiment, error bars 
correspond to standard deviation of averages derived from triplicate readings of each 
transfection mix. (B) Average raw values of luciferase for data in (A).
G418 and PTC124 may enhance HIV-1 frameshift in Vivo
To observe whether the putative drug-induced manipulation of the decoding center could 
have an effect on the frameshift mechanism, we repeated the transfection and drug 
treatment of 293A cells with the HIV-1 frameshift reporter pair (Figure 4-14). We 
observed a minor increase in frameshift with 0.5 mg/ml of G418, and no increase with 
lesser amounts. PTC124 almost doubled frameshift frequency at the highest 
concentration tested, which may partly be a result  of the putative luciferase:drug 
interaction. Paromomycin treatment resulted in a slight decrease in frameshift efficiency. 
Gentamicin had no effect.
Paromomycin has also been implicated in potential drug:RNA actions with the HIV-1 
genome: a portion of the dimerization signal in HIV-1 folds to assume a secondary 
structure that is theoretically modeled with similarity to the decoding region of the 16S 
rRNA. Paromomycin is thought to bind to this region and to prevent  dissolution of the 
RNA genome dimer, which in turn prevents reverse transcription and integration 
(McPike, Goodisman et al. 2002; Ennifar, Paillart et  al. 2003; Kaluzhny, Beniaminov et 
al. 2008). Our p2luc HIV-1 gag-pol junction containing reporter does not contain the 
dimerization signal and thus this specific interaction cannot be involved in the slight 





















































































































































































































Figure 4-14: Drug effects on HIV-1 frameshift. (A) Readthrough percentages based on 
dual luciferase assay results of the HIV-1 reporter pair transfected in 293A cells in 6 well 
format. Drugs were added in indicated amounts two hours after transfection. Graph is of 
representative experiment, error bars correspond to standard deviation of averages 
derived from triplicate readings of each transfection mix. (B) Average raw values of 
luciferase for data in (A).
B
Aminoglycosides do not increase readthrough of MoMLV in drug-resistant cells
To test whether the increase in MoMLV readthrough observed in the presence of 
aminoglycosides and PTC124 is a result  of interactions of aminoglycosides with the 
translation machinery and not the mRNA itself we repeated the transfection of the 13PK6 
reporter pair and subsequent drug treatment in 293T cells. 293T cells are neo-resistant; 
they  carry a bacterial resistance gene as a result of being immortalized with T-antigen 
encoded by a neo-resistance containing plasmid. None of the aminoglycosides increased 
readthrough of the MoMLV PK containing reporter (Figure 4-15).  Therefore inactivation 
of the drug results in no increase in normal readthrough levels.
Aminoglycosides increase MoMLV/PTC readthrough in Vitro
We tested the aminoglycoside effect on readthrough in in-vitro lysates to determine the 
maximum affect of the drugs on readthrough without the in-vivo limitations of drug take-
up and cell toxicity. We prepared IVT reactions with dual luciferase reporter constructs 
and increasing concentrations of aminoglycosides. After a 2 hour incubation we tested the 
reactions for luciferase expression using the DLA.   We tested G418 and paromomycin 
because of the enhancement of readthrough in vivo and effects on viral production. We 
did not test  PTC124 due to the controversy surrounding its interaction with luciferase; a 
fluorescent 13PK6 reporter (described in the appendix) will be more appropriate for 



















































































































































































































Figure 4-15. Drug effects on MoMLV readthrough in 293T neo-resistant cells.        
(A) Readthrough percentages based on dual luciferase assay results of the 13PK6 
reporter pair transfected in 293t cells in 6 well format. Drugs were added in indicated 
amounts two hours after transfection. Graph is of representative experiment, error bars 
correspond to standard deviation of averages derived from triplicate readings of each 
transfection mix. (B) Average raw values of luciferase for data in (A).
Increasing concentrations of G418 caused increasing enhancement of MoMLV 
readthrough (Figures 4-16 and 4-17). The highest final concentration of 20 ug/ml induced 
high levels of readthrough, but the raw values of the control luciferase reporter (FLuc-C 
and RLuc-C) indicate that overall translation was impaired. G418 had little effect on 
overall control reporter luciferase levels at concentrations of 5 ng/ml and 20 ng/ml, but 
also did not increase readthrough levels. At 78 ng/ml G418 caused a modest increase in 
readthrough and no effect on translation over the no drug control. Readthrough was 
increased 2 fold at .3125 ug/ml, with a corresponding reduction in control reporter 
luciferase levels. This trend of increased readthrough with decreased control luciferase 
expression continued with consecutively higher G418 levels. Therefore, although G418 
increases readthrough in a dose dependent manner, it appears to affect translation of all 
mRNAs. 
To determine whether the pseudoknot structure enhanced the drug-induced efficiency of 
readthrough we tested the no-pseudoknot containing reporter CollStop, described 
previously, in the IVT system. The experimental CollStop  reporter contains the same 
UAG G stop codon sequence as 13PK6, and allows comparison of the effects of the 
pseudoknot structure without variations of aminoglycoside sensitivity  to the 
tetranucleotide code. G418 addition seems to increase readthrough of the CollStop 
reporter at a higher efficiency (Figure 4-18).  Concentrations of 2 ng/ml to .3125 ug/ml of 
G418 caused a 2 to 5 fold increase in readthrough efficiency  of the CollStop reporter 






































































































































































Figure 4-16. G418 effects on MoMLV readthrough in vitro. (A) Readthrough 
percentages based on dual luciferase assay results of the 13PK6 reporter pair 
transcribed and translated in in-vitro reactions with G418.  Graph is of representative 
experiment, error bars correspond to standard deviation of averages derived from 
triplicate readings of each transfection mix. (B) Average raw values of luciferase for 
























































































Figure 4-17. G418 effects on MoMLV readthrough in vitro: fold change.               
(A) Fold changes in readthrough of the 13PK6 reporter in in-vitro reactions with G418. 
Graph shows results 4 trials, error bars correspond to standard error of the mean of 


















































































































Figure 4-18. G418 effects on CollStop readthrough in vitro. (A) Readthrough 
percentages based on dual luciferase assay results of the Collstop reporter pair 
transcribed and translated in in-vitro reactions with G418.  Graph is of representative 
experiment, error bars correspond to standard deviation of averages derived from 
triplicate readings of each transfection mix. (B) Average raw values of luciferase for 



















































Figure 4-19. G418 effects on Collstop readthrough in vitro: fold change.  Fold 
changes in readthrough of the CollStop reporter in in-vitro reactions with G418. Graph 
shows fold change for experiment in Figure 3-18, error bars correspond to standard 
error of the mean of average fold changes per condition. 
raw values of luciferase decreased below the linear range of the assay. This effect on 
overall translation was more pronounced with the CollStop reporter than with 13PK6, 
making consistency of reading at higher G418 concentrations unreliable and not 
correlative with G418 concentration. In addition, we noticed anomalies on the translation 
of the CollStop reporter in vitro. In several trials the rate of rluc was drastically  reduced, 
giving a high basal readthrough. This was not a consistent event, nor has the cause been 
determined, however, it  has made an absolute effect of G418 on this reporter difficult  to 
obtain. Therefore although CollStop reporter appears to be more sensitive to G418 than 
13PK6 at low levels, overall effects of G418 on the CollStop reporter cannot be 
determined from these experiments. 
We tested 13PK6 and CollStop with paromomycin. Readthrough of 13PK6 increased in a 
dose-dependent manner, with the highest concentration of paromomycin increasing 
readthrough to over 40% (~ 6 fold increase over basal levels) (Figure 4-20 and Figure 
4-21). Fold changes of CollStop readthrough efficiency were similar to these of 13PK6 
for paromomycin concentrations of 5 ng/ml to 1.25 ug/ml, with increases of 1.5X to 2.5X 
(Figure 4-22 and 3-23).  At the two highest concentration of drugs, 5 ug/ml and 20 ug/ml, 
the Collstop reporter had double the fold increase in readthrough efficiency compared to 
13PK6. The highest readthrough percentage measured was ~ 7% — a 16 fold increase 
over the average basal level of 0.5% . Levels of both 13PK6 and CollStop reporter 
constructs were relatively  unchanged by the addition of paromomycin with only small 


















































































































































































































Figure 4-20. Paromomycin effects on MoMLV readthrough in vitro.                     
(A) Readthrough percentages based on dual luciferase assay results of the 13PK6 
reporter pair transcribed and translated in in-vitro reactions with paromomycin.  
Graph is of representative experiment, error bars correspond to standard deviation of 
averages derived from triplicate readings of each transfection mix. (B) Average raw 





































































































Figure 4-21. Paromomycin effects on MoMLV readthrough in vitro: fold change.  
Fold changes in readthrough of the 13PK6 reporter in in-vitro reactions with 
paromomycin. Graph shows results 3-4 trials per condition, error bars correspond to 











































































































































































































Figure 4-22. Paromomycin effects on CollStop readthrough in vitro.                       
(A) Readthrough percentages based on dual luciferase assay results of the Collstop 
reporter pair transcribed and translated in in-vitro reactions with paromomycin.  Graph 
is of representative experiment, error bars correspond to standard deviation of averages 
derived from triplicate readings of each transfection mix. (B) Average raw values of 




































































































Figure 4-23. Paromomycin effects on Collstop readthrough in vitro: fold change.  
Fold changes in readthrough of the CollStop reporter in in-vitro reactions with 
paromomycin. Graph shows fold change for experiment in Figure 3-22, error bars 
correspond to standard error of the mean of average fold changes per condition. 
issues previously  described have also made it difficult to establish a consistent trend of 
the effect of paromomycin on this reporter. 
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Chapter 5: Discussion
In the work described here we have investigated trans-acting factors that  enhance 
readthrough at the MoMLV gag-pol junction. The cell-line dependent increase in 
readthrough by the cellular protein RPL4 indicates that  the cis-acting function of the 
MoMLV pseudoknot which promotes readthrough may not the sole modulator of 
readthrough in the cellular environment. The enhancement of MoMLV readthrough by 
aminoglycoside drugs (and possibly PTC124) also shows that the recoding at  the gag stop 
codon can be affected by extraneous factors.  We provide examples that increased 
readthrough and alterations to the gag;gag-pol ratio reduce retroviral replication, and that 
slight increases in gag-pol are enough to cause this effect. We demonstrate that the 
readthrough rate promoted by the pseudoknot can be pushed higher, and the basal level 
does not represent an inherent ceiling of readthrough in the cell. In addition to the 
specific impact on MoMLV replication, we show that the process of proofreading and 
resultant stop codon suppression can be affected by  compound factors in the cell. This 
implies that there are potentially many levels of control in the eukaryotic proofreading 
and termination mechanism that remain to be elucidated. 
RPL4
Here we demonstrate the phenomenon of recoding enhancement by  the trans-acting 
cellular protein, RPL4. We show that RPL4 is capable of increasing readthrough of the 
stop codon at the gag-pol junction. Co-transfection of cells with RPL4 cDNA and the 
DLA reporter constructs results in a dose-dependent increase in readthrough. 
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Interestingly, this increase is cell line dependent. This suggests that participation of other 
cellular factors with different expression profiles may also influence readthrough, and are 
able to block or compensate for the RPL4-induced effect. We tested a panel of other 
ribosomal proteins to rule out the possibility  that addition of extra RPL4 mRNA/protein 
to the cellular environment was causing a general disruption in the stoichiometry of 
ribosomal proteins, and that increase in readthrough was a non-specific effect due to a 
ribosomal protein imbalance. Although proteins L7 and S20 showed a modest increase in 
MoMLV readthrough over basal levels, all other proteins tested showed had no effect at 
all on readthrough, indicating that the RPL4 effect on readthrough is not a result of 
general non-specific disruption of the translation machinery. 
Over-expression of RPL4 has proven difficult to verify via Western blot. The use of tags 
at either the N- or C-terminus eliminate the readthrough enhancement; the N-terminally 
tagged versions can be visualized with anti-Flag antibodies, but are not functional in 
enhancing readthrough. C-terminally tagged constructs can not be seen, do not enhance 
readthrough and may not be produced in vivo. Use of commercial polyclonal and 
monoclonal antibodies allowed visualization of RPL4, but the signal did not increase 
with transfection of RPL4 expression vectors; we concluded that the regulation of RPL4 
is tightly  controlled, and that the increase may not be detectable by  Western blot. 
However, we have shown that RPL4 mRNA is transcribed in 293A cells, and that 
enhancement of readthrough is not  due to an RNA effect. We surmise that very small, or 
transient, increases in the levels of protein may be responsible for the effects.
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We investigated whether RPL4 only affected the MoMLV pseudoknot or was able to 
perturb other recoding events.  HIV-1 frameshift  and Sindbis “leaky stop  codon” 
reporters both showed enhancement of recoding with RPL4. Because HIV-1 utilizes a 
slippery  sequence and a stem-loop structure, and the portion of the Sindbis recoding 
signal used here is merely a leaky stop codon without a secondary structure, we can 
conclude that the RPL4 enhancement of MoMLV readthrough is not dependent 
specifically on the MoMLV gag-pol junction sequence, or even on a general pseudoknot 
motif. 
To clarify whether RPL4 was allowing readthrough of any premature termination codon, 
we constructed a derivative of the MoMLV pseudoknot reporter, ScrPK, that harbored a 
scrambled pseudoknot sequence with no predicted secondary structures This reporter 
showed no enhancement of readthrough with RPL4 addition, but overall levels of 
luciferase were much lower than with the wild-type reporter pair. Additionally, in the 
scrambling of the pseudoknot sequence the nucleotide immediately following the UAG 
stop codon was changed from G to A. The UAG A tetranucleotide sequence has 
inherently  lower readthrough than UAG G.  We tested another version of the ScrPK 
reporter which included the flanking sequences and the native UAG G stop codon 
sequence, but the levels of rluc expression were also very low, indicating a problem with 
overall expression of the constructs. The abolishment of readthrough and/or the 
secondary  structure likely decreased the stability of these transcripts due to increased 
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susceptibility to the NMD pathway.  Subsequently, the translation of the both luciferase 
proteins were affected to the extent that the data was below the linear range of our DLA. 
Attempts to circumvent NMD with dominant negative UPF1, a major regulatory factor in 
the decay of premature-stop codon containing mRNAs, were unsuccessful due to other 
effects on the translation and/or termination cycle. Reporter constructs containing the 
RSE from Rous Sarcoma Virus, which provides protection from NMD, also failed to 
show adequate translation of the rluc reporter. A reporter construct containing a portion of 
the collagen reading frame with an artificial stop  codon had rluc levels comparable to the 
wild-type MoMLV 13K6 reporter was created. RPL4 did not appear to significantly 
increase readthrough levels of this construct, indicating that the effect is not general to 
premature termination codons.  In addition, it seems unlikely that RPL4 can increase 
suppression of normal termination events, given the general health of transfected cells. 
Rather, RPL4 seems to enhance the propensity  for recoding to occur in the presence of 
some distinct recoding signal. 
We confirmed that RPL4 does not rescue an inactive pseudoknot mutant, in accordance 
with the apparent requirement for a recoding signal. RPL4 increased readthrough of a 
hyperactive pseudoknot mutant in a manner consistent with the effect on the wild-type 
MoMLV pseudoknot; overall readthrough was higher, but the fold change above baseline 
was similar to that seen with 13PK6. This shows that the RPL4 enhancement does not  act 
synergistically  with nor is eclipsed by the mechanism that allows for more readthrough in 
the hyperactive mutant. Readthrough may be controlled in several ways during 
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translation. We show also that RPL4 enhances readthrough through suppression of 
termination of all three stop codons, despite the natural resistance to readthrough that 
occurs with UAA. We also show that RPL4 works additively, and is not eclipsed by the 
aminoglycoside G418. 
It is important to note that crystal structures of the aminoglycoside paromomycin bound 
to the 16s rRNA of the bacterial decoding center show displacement of the proof-reading 
nucleotides A1492 and A1493 from their native position which also occurs upon cognate 
codon:anticodon interactions. The displaced nucleotides are not in the same orientation 
with paromomycin binding as they  are in a cognate codon:anticodon interaction. 
Therefore, it seems it is the displacement from the default position of these nucleotides 
that is the catalyst of proofreading, not the specific orientation that they  assume. If RPL4 
were simply disrupting the normal alignment of the molecular caliper in the 18S rRNA, 
either by binding the pseudoknot and/or ribosome, then addition of an aminoglycoside 
would not be expected to add to readthrough. Likewise, the ability of aminoglycosides to 
increase readthrough is extremely  sensitive to stop codon identity and the tetranucleotide 
code. The RPL4 enhancement of readthrough does not share these restrictions. Taken 
together, these findings show that RPL4 may  be working beyond manipulation of the 
decoding center to increase readthrough.
Overexpression of the termination factors eRF1 and eRF3 with 13PK6 had no effect on 
readthrough in our DLA. However, transfection of these factors, or eRF1 alone abolished 
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the RPL4 effect. We show also that this is not a general affect  of co-transfection of 
multiple expression constructs since co-transfection of RLP4 and RPL7 did not similarly 
abolish the enhanced readthrough. Therefore, RPL4 overexpression may be interfering 
with normal termination, and this effect is overcome by  increased expression of release 
factors. If readthrough is viewed as a competition between termination and non-cognate 
incorporation of glutamine at a UAG stop  codon (prompted by a change in pseudoknot 
conformation), RPL4 could be sequestering or preventing termination factors from 
recognizing the stop codon, and allowing a longer temporal window for the pseudoknot 
to assume the active conformation. Alternatively, acceptance of the tRNA in the A site is 
also dictated by  GTP hydrolysis; RPL4 could be altering the rate of GTP hydrolysis by 
some mechanism, potentially speeding it  up and making proofreading less rigorous. Here, 
a competition between termination and readthrough could possibly be adjusted by an 
increase in the availability of release factors to recognize stop codons and catalyze 
termination.
Paradoxically it has been shown that knock-down of eRF1 reduces readthrough in a one 
plasmid reporter system (Carnes 2003) (although affects on general termination via a 
control reporter were not explored, and it could not be verified that  the decrease in 
readthrough was not due to overall suppression of termination.) More recent work has 
documented a role for eRF1 in HIV-1 frameshift that is not related to the position of the 
stop codon; depletion of eRF1 increases HIV-1 frameshift in HeLa cells, yeast and in-
vitro DLA assays (Kobayashi, Zhuang et al. 2010). These findings correlate with our 
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observations and eRF1 be a common factor in the RPL4 enhancement of readthrough and 
frameshift. 
Knockdown of RPL4 has been shown to decrease rRNA processing (Yang, Henning et al. 
2005), and it has been proposed that RPL4 stimulates ribosome biogenesis. We wondered 
if a simple explanation for the RPL4 enhancement of readthrough was that transfection of 
RPL4 and transcription and/or expression acted as a trigger in some cells to produce more 
ribosomes. In IVT reactions, with set amounts of ribosomes and elongation and 
termination factors, we do not  see an RLP4 specific increase in readthrough. We 
examined the expression of another ribosomal protein, RPL10a, upon transfection with 
the RPL4 expression construct. We saw no detectable increase in RPL10a levels in either 
cell lines that responded to RPL4 or in those that did not. We then used qPCR to measure 
28S rRNA and although we saw only  a slight increase in levels of 28S rRNA with RPL4 
overexpression, and this increase did not correlate with RPL4 responsiveness. Thus, 
RPL4 may increase the amount of ribosomes, but this alone seems unlikely to promote 
the increase in readthrough. The lack of effect in IVT reactions may  be due to increase of 
an additional, unknown factor that could also be the distinguishing element between 
RPL4 responding and non-responding cell lines. 
Readthrough of the gag stop  codon allows the optimal proportion of gag and gag-pol 
proteins to be translated for virus replication.   It has been suggested that  slight deviations 
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from the normal gag:gag-pol ratio will affect viral replication. The approximately 2-fold 
RPL4 enhancement readthrough, although consistent and unique, is moderate compared 
to the changes seen in the study of other biological processes, and therefore we 
investigated whether this relatively  small change was relevant to viral replication.  We 
show that RPL4 increased readthrough can indeed profoundly limit the replicative ability 
of the virus. Consistent production of gag but  lower capsid levels in cells transfected with 
RPL4 indicates that the gag is produced, but there is a block of normal processing. 
Analysis of virus produced in the presence of RPL4 suggests that less virus is released 
from producer cells. In addition to verifying the effect of RPL4 on MoMLV readthrough, 
these results further stress the importance of the maintenance of the gag:gag-pol ratio in 
retroviral replication.   
Thus we show that RPL4 is a positive enhancer of recoding, which in turn has negative 
effects on retroviral replication. Although the precise mechanism of RPL4’s effect is still 
unclear, our work indicates participation of an additional factor(s) which have differential 
expression among cell lines. The RPL4 effect appears to be independent of other ways of 
modulation of readthrough, and may interfere at a different point  in the mechanisms of 
translation fidelity than the point affected by the pseudoknot. Given RPL4’s effect on 
frameshift as well as readthrough, this modulation of recoding may occur as a more 
general suppression of termination outside the ribosome, or involve another facet of 
tRNA acceptance on the ribosome.
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Roles for several ribosomal proteins in extra-ribosomal translational control have been 
discovered (reviewed in (Warner and McIntosh 2009).  RPL13A is phosphorylated as part 
of the cellular response to IFNγ; phosphorylated RPL13 disassociates from the ribosome 
and forms a complex that binds the 3‘ UTR of certain mRNAs and prevents their 
translation (Kapasi, Chaudhuri et al. 2007).  RPL38 regulates the translation of hox genes 
during embryonic development in a tissue specific manner — it prevents proper assembly 
of the 80S ribosome, thereby disrupting normal initiation (Kondrashov, Pusic et al. 2011). 
Microarray analysis of ribosomal protein expression in various cell types shows 
differential expression of RPL38 and many ribosomal proteins, indicating that many 
ribosomal components could have extra-ribosomal functions. This also raises the 
possibility of heterogeneity in ribosome composition; not all ribosomal proteins may be 
present in all ribosomes (Kondrashov, Pusic et al. 2011).
There are ribosomal proteins that serve as “ribosome biosynthesis sentinels” (Warner and 
McIntosh 2009) and defects in ribosome biogenesis result in the activation of p53 and 
subsequent apoptosis. RPL11 can interact with H/MDM2 and sequester it, thereby 
stabilizing p53 (Lohrum, Ludwig et al. 2003); treatment of cells with low levels of 
actinomycin D to disrupt the transcription of ribosomal components increases the 
association of RPL11 with H/MDM2 and results in p53 mediated cell cycle arrest. RPL5 
interacts with H/MDM2 (Marechal, Elenbaas et al. 1994), both alone and in conjunction 
with RPL11 (Horn and Vousden 2008), to protect p53. RPL23 also interacts with H/
MDM2 to in a manner similar to RPL5 and RPL11(Dai and Lu 2004). Interestingly, 
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RPL5, RPL23 and RPL11 can interact  with c-myc (Dai, Sears et al. 2007) and RPL11 
inhibits c-myc response to ribosomal stress (Dai, Arnold et al. 2007) and induces 
degradation of c-myc mRNA (Challagundla, Sun et  al. 2011). Disruption of ribosome 
biogenesis may allow unassembled ribosomal proteins to perform extraribosomal 
functions to respond to the deregulation and promote apoptosis (Warner and McIntosh 
2009).
The mechanism by which RPL4 alters translation to allow greater readthrough remains 
unclear. RPL4 has multiple roles in the cell, and may affect readthrough in a variety of 
ways (Figure 5-1). In eukaryotic cells RPL4 has a necessary role in ribosome biogenesis 
as it  is involved in the processing of rRNA; therefore its expression pattern is expected to 
be consistent in all cell types. Paradoxically, the cell line dependence of the RPL4 
response implies either alternate regulation of RPL4 itself or differential expression of an 
additional factor that is involved in readthrough. RPL4 expression has been associated 
with apoptosis in a rat neuronal tumor line treated with 5AzC (Kajikawa, Nakayama et al. 
1998), but  a later study by  the same group did not find the same results in embryonic rat 
brain tissue. Instead, it appears that there is differential expression of RPL4 during 
development of the rat brain, with increased RPL4 expression corresponding to 
differentiation and proliferation, perhaps due to higher level of protein synthesis as 
development occurs (Ueno, Nakayama et al. 2002). In addition, the role of RPL4 as a 
stimulator of the transcription of c-myc seems to suggest  a pro-growth, rather than 
regulatory, function. Just as specific ribosomal proteins, but not  all, stimulate cell cycle 
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arrest (Sun, Wang et al. 2010), others may upregulate ribosomal biogenesis. RPL4 may 
stimulate the transcription of one or many other factors that contribute to the 
enhancement of recoding. It also may be worthwhile to consider the role of RPL4 as part 
of a cellular anti-viral response, although it is unlikely that it dissociates from the 
assembled ribosome in the manner of RPL13a. 
In many cell lines, RPL4 expression appears constant. RPL4 is used as a standard in 
qPCR, showing stable expression in many tissue types such as equine embryos (Paris, 
Kuijk et al. 2011), chicken embryo fibroblasts (Yue, Lei et  al. 2010), human ovarian 
tissue (Fu, Bian et al. 2010), and murine liver (Takagi, Ohashi et al. 2008). Our attempts 
to visualize levels of normal and over-expressed RPL4 among various cells types did not 
reveal any significant detectable differences in protein by Western blot. While this is 
likely due in part to the antibodies used, the difficulty in visualizing changes in RPL4 
may be considered evidence that the expression of RPL4 is tightly regulated under 
normal circumstances and large differences in levels are not tolerated by the cell. 
However it may be possible to visualize a significant transient increase that  might occur 
in our experimental system with alternately tagged versions and we are currently 
attempting to clone a readthrough enhancing RPL4 construct with an interior Flag tag. 
This would also allow visualization of RPL4 in various locations in the cell. RPL4 has 
nucleolar and nuclear localizations as well as the ribosomal position and perhaps an 
increase in RPL4 mRNA from the expression construct is a stimulus for reorganization of 
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Figure 5-1. Potential Mechanisms for RPL4 enhancement of Recoding. RPL4 may 
influence recoding directly or indirectly through many roles in the cell. It may trigger 
upregulation of ribosomes in the nucleolus; may increase the transcription of another 
gene associated with an aspect of translation or termination; or may interact directly 
with a termination or other factor in the cytoplasm. An abundance of RPL4 may also 
interact directly with mRNA to enhance stability of secondary structures  or with the 
ribosome itself to perturb normal aa-tRNA selection or decoding. 
RPL4 could lead to readthrough enhancement. A reliable way to visualize exogenous 
RPL4 also would allow quantification of RPL4 in different cellular fractions, as well as 
imaging by immunofluorescence. 
To understand how RPL4 is affecting readthrough, it will be necessary  to determine 
whether the enhancement of recoding relies on a predisposition of an mRNA to allow a 
miscoding event. We presently lack a definitive non-viral non-recoding control for 
gauging RPL4’s effect on readthrough in the context of simple premature termination. 
Our attempts at designing control constructs have not been entirely  successful due to 
limitations of detection, mRNA stability or other expression issues. Exploration of the 
RPL4 effect using an alternative reporter system to the DLA may  allow proper expression 
of a non-recoding control and provide a clearer result. 
The apparent link between RPL4 and release factors is a phenomenon that can be further 
explored. The fact that RPL4 affects both readthrough and frameshift  argues for its 
specificity to enhance recoding of mRNAs that contain a stimulus for miscoding. eRF1 
has also been implicated in both readthrough and frameshift, and may have a role in 
mRNA surveillance that is not  limited to interactions with the stop codon (Kobayashi, 
Zhuang et al. 2010). Thus, RPL4 may interfere with the functions of eRF1. Analysis of 
physical interactions between RPL4 and release factors is an appropriate approach to 
understanding the relationship  between these proteins and their effect on readthrough. We 
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are currently optimizing experimental conditions for immunoprecipitation of cellular 
lysates to probe for RPL4:eRF1 interactions.
If RPL4 is preventing termination, i.e. interaction with eRF1, this process may be 
visualized with a footprinting assay in a reconstituted translation system as per the 
Pestova lab (Pestova and Hellen 2003; Pestova and Hellen 2005; Alkalaeva, Pisarev et al. 
2006). In these assays, binding of release factors to the ribosome results in a 
conformational change in ribosome structure which can be visualized as a “two 
nucleotide forward shift of the toeprint” (Alkalaeva, Pisarev et al. 2006). This would 
require production of a soluble form of RPL4 protein. We were not successful with our 
attempts to recover RPL4 produced in bacteria after cleavage of the GST tag and further 
optimization of the purification and recovery of RPL4 are needed. It  may be possible to 
produce RPL4 in a human in-vitro lysate system if an appropriate purification scheme 
can be developed. The ability  to test RPL4 in a customized reconstituted translation 
system would also help identify additional factors that may be involved in the 
readthrough and may even allow study  of the point of RPL4 effect on readthrough 
through analysis of GTP hydrolysis during the proofreading process in a controlled 
environment. 
The cell line dependence of the enhancement of readthrough by  RPL4 can also be 
explored. As RPL4 has been shown to stimulate the transcription of myb-regulated genes, 
microarray  analysis of myb-transcribed genes in responding and non-responding cell 
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lines would be a logical first step. Additionally, mass spectrometry  analysis of RPL4-
bound proteins in responding and non-responding cells could reveal differences in 
interactions between lines that cannot be detected by  microarray. FACS analysis with 
fluorescent recoding reporters as described in the appendix is also a potential tool for 
broadening our understanding of the network of factors involved in recoding. 
Identification of factors associated with RPL4 in endogenous and overexpression 
conditions in responding and non-responding cell would contribute not only to the 
understanding of the specific RPL4 effect on recoding, but would add to the knowledge 
of general eukaryotic translation regulation. 
Readthrough promoting drugs
We have examined the effect of aminoglycoside antibiotics and the small molecule 
PTC124 on the readthrough efficiency of the MoMLV gag-pol junction. We show that 
exposure of mammalian cells to specific aminoglycosides can result in a dose dependent 
increase of readthrough at the MoMLV junction as measured by  our dual luciferase 
reporter system.  G418 and paromomycin exhibit the greatest effects on readthrough in 
vivo. Exposure of cells to PTC124 also appeared to increase readthrough of the 13PK6 
dual luciferase reporter, but this effect may  be exaggerated by drug:luciferase 
interactions. Amakacin, streptomycin, kanamycin and gentamicin demonstrate little effect 
on readthrough in vivo. As the aminoglycosides vary  only  slightly  from each other in 
terms of structure, the specific configurations of the G418 and paromomycin result  in 
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their efficacy in promoting readthrough of 13PK6. Both G418 and paromomycin have an 
OH at the 6’ position of ring I, which may be responsible for facilitating a reaction with 
the 18S rRNA that favors readthrough (Figure 4-2).  However the structure of an 
additional sugar (ring III) is different between the two, and is attached at a different 
position on ring II. The combination of ring III structure and linkage may contribute to 
toxicity of G418, and/or higher tolerance of paromomycin.
We show that exposure of virus-producing cells to readthrough promoting drugs can 
affect viral production. Expression of the fluc reporter gene was reduced in all cells 
infected with recombinant virus produced in the presence of drugs.  Virus from G418 
reduced cells was reduced from 2 to 4 logs compared with the no-drug control. However, 
toxicity  is an issue with G418, which makes interpretation of its effects in vivo difficult. 
Rluc levels in producer cells exposed to G418 were reduced in all trials and a viability 
assay of G418 treated cells confirmed that viability is reduced as G418 concentration and 
readthrough efficiency increases. Therefore we are unable to determine if it is the 
readthrough promoting actions of G418 or its general toxicity to the producer cells that is 
responsible for decreased infection. 
Paromomycin had the greatest effect on viral replication with the least disruption of 
translation in producer cells (measured by rluc expression), with up to a 10 fold reduction 
in signal reduction.  PTC124 also reduced expression of the viral-conferred firefly gene 
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in infected cells 2- to 5-fold; since the naive cells are not exposed to PTC124, this effect 
is independent of any drug:luciferase artifacts in the DLA.  Amikacin treated cells 
displayed the least effect on virus produced, but display  10 - 50% reduced signal as 
compared to the no-drug control.  Producer cells treated with PTC124 show some 
reduction in renilla expression in producer cells, while amikacin does not affect rluc 
signals. Therefore, exposure of mammalian cells to readthrough promoting drugs may be 
a method for controlling production of viruses that utilize stop codon suppression. 
We show that the aminoglycoside effects on readthrough in the DLA are nonexistent in 
293T “neo”-resistant cells. Therefore, inactivation of the drug prevents its ability  to 
enhance readthrough.  We verify the flexibility of our experimental system with a test of 
the leaky  stop  codon Sindbis reporter, which shows expected greater increases in 
readthrough due to increased sensitivity to aminoglycosides. We also show that 
aminoglycosides are specific for increasing readthrough and not frameshift at the doses 
tested with a survey of drugs and the HIV-1 dual luciferase reporter pair.
We examined the affects of G418 and paromomycin on readthrough in an in-vitro system. 
We show that G418 is able to promote high levels of readthrough, but that these increases 
correspond with overall translational dysfunction. Readthrough of the non-pseudoknot 
containing reporter CollStop also reaches high levels with G418. At high concentrations 
of G418, there was a large spike in readthrough frequency of Collstop, with increases of 
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up to 40% readthrough (data not shown). However, the levels of control reporter levels 
were also affected at this point, making interpretation of the G418 effect unreliable. The 
mechanism by  which G4I8 works may affect translation of all mRNAs, and thus a 
predisposition of an mRNA to recoding may be eclipsed by a a general effect on 
translation. Paromomycin stimulates moderate increases in readthrough frequency  in a 
dose dependent manner, with less negative impact on translation of the reporter 
constructs. This result pertains to both 13PK6 and CollStop reporters. Therefore, 
aminoglycoside effects in readthrough are not limited to overall disruption of all 
translational events. The interaction of paromomycin with the eukaryotic ribosome may 
be intrinsically tied to recoding signals or readthrough of premature termination codon 
and not to a general miscoding mechanism that functions at any codon. However, 
verification of this theory is beyond the scope of these experiments. 
Our work with aminoglycosides also offers novel insight into eukaryotic translation in the 
handling of miscoding events. We show that  readthrough of the MoMLV pseudoknot can 
be pushed beyond normal levels upon exposure to certain aminoglycosides; the 
mechanism by  which the MoMLV pseudoknot stimulates readthrough is not exclusively 
the only way to promote recoding on the eukaryotic ribosome. Likewise, aminoglycoside 
interactions do not eclipse the readthrough stimulated by the pseudoknot, or the 
additional enhancement by RPL4. This additive effect of factors on readthrough implies 
many points of regulation that can be altered to allow miscoding. 
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We also demonstrate that the conventional wisdom that ‘antibiotics won’t do anything for 
a viral infection’ may not be entirely correct. Our survey of aminoglycoside drug affects 
on MoMLV readthrough shows that it  is possible to alter the rate of miscoding slightly, 
but enough, to affect viral replication. We tested a limited number of aminoglycosides, 
and the affects of paromomycin are encouraging. Because aminoglycosides work poorly 
on eukaryotic ribosomes, further tests may reveal others that work just well enough to 
promote viral readthrough without great toxicity. As with the RPL4 effect, a properly 
expressing non-viral non-recoding control is needed to distinguish general effects on 
translation termination from specific enhancement of viral readthrough. 
Final thoughts
We have demonstrated that trans-acting factors can affect the frequency  of recoding of 
mRNAs by the eukaryotic ribosome, indicating that regulation of recoding is not 
regulated exclusively by  mRNA secondary  structure. Greater understanding of the 
phenomenon of recoding can be gained through structural studies, and the visualization 
of the pseudoknot on the ribosome through cryo-EM will be a powerful source of 
information that  our lab is still working towards. We are also considering single molecule 
imaging of recoding events utilizing fluorescent-tagged translation components (for 
review see (Petrov, Kornberg et al. 2011) and will be investigating the feasibility  of 
applying these techniques to our studies in the near future.
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Thus we have laid important groundwork for understanding the process of miscoding in 
eukaryotic translation. We have revealed an alternate role for RPL4 as an enhancer of 
readthrough, adding to the known functions of ribosomal proteins beyond their traditional 
ribosomal purpose. We also reveal a non-traditional application of aminoglycoside 
antibiotics to alter translation of retroviral proteins. This work provides many 
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Functional Pseudoknot FACS screen
In effort to further explore the phenomenon of readthrough, we endeavored to use FACS 
technology to screen for additional cellular factors that could affect readthrough.  Goff 
lab member Brian Houck-Loomis designed a dual fluorescent reporter (2FP) containing 
the MoMLV PK flanked by DsRed1 and eGFP. This reporter would allow visualization of 
readthrough in a live cell population. It would be possible to sort cells expressing the 
fluorescent readthrough reporter with FACS analysis and to create populations of cells 
with changes in readthrough levels that could be further analyzed. We anticipated that we 
could use an over-expression library of cellular proteins to find those additional factors 
that affect readthrough (Figure A-1). The ability  to collect candidate cells and produce 
clonal populations would allow for the identification of these factors by PCR or 
microarray. 
The 2FP reporter cassette was cloned into the lentiviral vector QXCIP, which contains a 
lentiviral packaging signal and the puromycin resistance gene under the expression of an 
IRES for a selection marker (Figure A-1).  Puromycin inhibits translation as a chain 
terminator – the molecule is added to the nascent peptide, but the molecule cannot 
participate in peptide bond formation with a subsequent amino acid.. It does not effect 
recoding inthe manner of the aminoglycosides. We created recombinant virus using the 
MoMLV 2FP reporter, the pCMV-intron plasmid containing MoMLV gag:pol, and an 
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• Make virus (3 plasmid system)
• Infect 293A cells, drug selection (Puromycin)
• Establish MLVPK-2FP reporter line
• Select a clone via FACS for infection w/cDNA library.
Criteria: consistent level of eGFP, responsive to RPL4 
and PABP transfection, with discernible increase/
decrease in readthrough (eGFP/DsRed1) 
• Infect with cDNA library
• Sort with preparative FACS to collect cells with 
altered readthrough levels.
• Analyze insertions to identify factors that modulate 
readthrough.
Ψ IRES PURO
Figure A-1. Schematic of 2FP reporter construct and FACS screen overview.  (A) 
MoMLV 2FP reporter cassette with the wildtype gag-pol junction between DsRed1 
and eGFP, in the pQCXIP backbone. (B) Overview of proposed FAC-based functional 




expression vector for VSV-G envelope. We also created virus containing either DsREd1 
or eGFP in PQCXIP for single color controls for the FACS analysis. We transfected 
293T cells with the 3-plasmid recombinant virus mix, and harvested virus 48 hours post 
transfection. We infected naïve 293A and Rat2 cells with either single color control or the 
2FP virus. Forty-eight hours later we placed the infected cells under puromycin selection 
to choose only cells with the integrated 2FP reporter.  
Single color control (Figure A-2) and the MoMLV 2FP pool were analyzed via FACS 
(Figure A-3).  The MoMLV pool was distinguishable as a double positive population. 
MoMLV 2FP cells were plated at a dilution to give a cell per well of 96 well plate. Clonal 
lines were established and were analyzed by FACS for DsRed1 and eGFP expression. 
We calculated readthrough as the ratio of eGFP intensity/Dsred1 intensity based on the 
mean fluorescence per cell using FlowJo FACS analysis software. We were able to 
estabalish lines from clones #1, #18 and #21. The parent pool and three clones showed 
similar ratios of eGFP/DsRed1 (Figure A-4). The clones had fewer double positive cells 
overall, although the cells were maintained under puromycin selection.  Clone #18 had a 
slightly higher and broader range of apparent readthrough values perhaps indicating a 
difference in cellular environment that could support greater recoding. 
To verify  that the 2FP reporter system was sensitive enough to register a change in 








Figure A-2. MoMLV 2FP and single color controls. FACS analysis of DsRedI and 
eGFP expression of normal (“unstained”) 293A cells, control 293A lines stabling 
expressing either DsRed1 or eGFP, and 293A cells stabling expressing the MoMLV 2FP 
construct. Threshold for expression of fluorescent reporters in readthrough graphs (PE vs. 
FITC) based on levels from single positive controls. All cells were initially gated on live 


































































































































































































































































































































































































2FP Clones #1 #2 #14
#18 #21 #22
Figure A-3. Readthrough in MoMLV pool and clones. FACS analysis of readthrough 
in parent pool of 293A cells stabling expressing the MoMLV 2FP construct and selected 
clones. Threshold for expression of fluorescent reporters in readthrough graphs (PE vs. 
FITC) based on levels from single positive controls. All cells were initially gated on live 
and single cells populations. 
MoMLV 2FP Pool
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Figure A-4. Readthrough in MoMLV 2FP pool and clones. Histogram of readthrough 
in parent pool of 293A cells stably expressing the MoMLV 2FP construct and selected 
clones. Readthrough is determined by ratio of average mean intensity of eGFP/DsRed1 
based on data from Figure A-3. 
the cells by  FACS 48 hours post transfection (Figure A-5). In our work on RPL4 we 
searched for additional translation/termination factors that may affect recoding. One of 
the proteins we tested was PABP; it has a role in termination, associating with eRF3, and 
may also contribute to the surveillance of mRNA by  NMD factors (We cloned PABP and 
tested its affects on readthrough; PABP was able to decrease readthrough by  about half in 
293A cells as measured by the DLA, but did not affect viral replication in a transducing 
virus assay.)  Neither PABP nor RPL4 caused a change in readthrough in the 2FP pool 
and clones as detected by FACS in cells analyzed 2 day post transfection. 
GFP and its derivatives have an approximate half-life of 24 hours. Therefore we thought 
perhaps subtle changes in eGFP levels were indiscernible against the background of basal 
expression at the time we analyzed the cells. We transfected clone #18, which had a 
broader range of eGFP/DsRed1 expression, with RPL4 and PABP and analyzed the cells 
by FACS 48 hours post transfection (Figure A-6). In addition we confirmed the ability  of 
clone #18 to respond to RPL4 by DLA with the 13PK6 reporter pair and RPL4 (Figure 
A-7); RPL4 increased readthrough at the higher concentrations tested. However in the 
FACS analysis we could not detect  any increase in readthrough associated with RPL4. 
We observed a decrease in readthrough in the PABP transfected cells, demonstrating that 
the experimental system was sensitive to changes in readthrough. The RPL4 effect has 
been observed to occur in a short period post transfection; RPL4 could be down-regulated 
by the time the of FACS analysis. 
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Figure A-5. Readthrough in MoMLV 2FP pool and clones transiently transfected 
with RPL4 and PABP. Histogram of readthrough in parent pool of 293A cells stabling 
expressing the MoMLV 2FP construct and selected clones transfected with mRPL4 or 
PABP. FACS analysis performed 2 days post transfection.
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Figure A-6. Effect of RPL4 and PABP on readthrough in MoMLV 2FP pool and 
clones. Histogram of readthrough in clone 18 transfected with mRPL4 or PABP. FACS 















































































Figure A-7. Effects of RPL4 on 13PK6 readthrough in MoMLV 2FP clone 18.             
A. Readthrough percentages based on dual luciferase assay results of the 13PK6 reporter 
pairs co-transfected with increasing amounts of RPL4 into MoMLV 2FP clone 18 in 96 
well format. Error bars correspond to standard deviation of averages derived from 
triplicate readings of each transfection mix. B. Average raw values of luciferase for data 
in A.
To overcome the background of fluorescent proteins in the stably expressing MoMLV 
2FP line we tested the reporter with a transient transfection. We transfected 293A cells 
with the MoMLV 2FP reporter and RPL4. We could not detect an increase in readthrough 
as measured by  the eGFP/DsRed1 levels in the cells (Figure A-8). However, a higher 
percentage of cells expressed fluorescent proteins in samples transfected with RPL4. 
This indicates differential expression of the reporter plasmid in the presence of RPL4. 
RPL4 may enhance the half-life or stability of the MoMLV 2FP construct, either by an 
RNA:protein interaction or by protection against NMD. Alternately, RPL4 may be 
predisposing a portion of the cellular population to allow readthrough; perhaps the 
increase in readthrough measured in DLA is an aggregate of a population where more 
readthrough product is produced by  more singular cells, not a general increase in all cells. 
However, further experiments would be needed to verify this theory.
Concurrent with the transient transfection trial, Cardno et al. published a survey of 
various combinations of fluorescent proteins and their use in bicistronic reporters 
(Cardno, Poole et  al. 2009). Our reporter uses DsRed1 as the upstream reporter, and 
eGPF as the readthrough product. The LSR11 flow cytometer is optimized to read eGFP, 
but not DsRed1. In addition DsRed1 functions as a tetramer, and more protein needs to be 
produced in order to detect a signal. Therefore we feared the intensity of the DsRed1 was 
compromised. A low upstream reporter signal coupled with very intense eGFP might 
make a twofold increase in eGFP hard to visualize on the log scale. Considering the work 
of Cardo, we decided to redesign the 2FP reporter,  with eGFP as the upstream product. 
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Figure A-8. RPL4 effect on readthrough in transient transfection of MoMLV 2FP.    
(A) FACS analysis of readthrough in 293A cells transfected with RPL4 and the 
MoMLV 2FP reporter construct. Threshold for expression of fluorescent reporters in 
readthrough graphs (PE vs. FITC) based on levels from single positive controls. All 
cells were initially gated on live and single cells populations. (B) Histogram of 
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We replaced DsRed1 with mCherry, which is brighter and functions as a dimer, for use as 
the readthrough reporter. The new 2FPgr cassette has been cloned into pcDNA3.1 to use 
in transient transections, and our lab has tested it in the study of NMD. However, the 
signal of mCherry  was still dim as detected by our OMEGA plate reader. We have not yet 
tried it in our recoding assays. We have recently installed a tabletop GUAVA flow 
cytometer and will be using testing the 2FPgr reporter for further use. 
Cryo-EM structure: The pseudoknot on the ribosome
Our lab has obtained the structure of the MoMLV gag-pol junctions through NMR 
analysis and confirmed it to be a classic H-type pseudoknot. Although this structure has 
revealed a partial mechanism for the promotion of readthrough based on the equilibrium 
between an inactive and active conformation, interactions with the ribosome are still not 
known. Therefore we have endeavored to visualize the MoMLV pseudoknot on the 
ribosome by  way  of cryo-EM microscopy. Most cryo-EM structures have been resolved 
using bacterial ribosomes; eukaryotic translation is more complex and structures are 
relatively rare. This project  has not been completed; the preparation of the sample with 
mammalian ribosomes is a unique situation and has required the novel application of 
many experimental techniques.  However, we are working toward refining a system that 
will allow us to freeze translation at the act of readthrough. 
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Cryo-EM requires a large number of homogenous particles in a sample. The 3-
dimensional structure is constructed of thousands of images that are manipulated by 
Fourier transformation to allow alignment. These are further analyzed by computational 
algorithms that reference common components to construct a composite image.  Although 
ribosomes have large regions of homology, different populations in various stages of 
translation have been distinguished, i.e. racheted and non-racheted. However, rarer events 
approach signal:noise threshold. Because readthrough occurs about 5% of the time, it 
would be difficult to separate a large enough readthrough population under normal 
conditions to distinguish from noise in a cryo-EM  reconstruction. In addition, the NMR 
structure suggests that  the pseudoknot adopts an alternate confirmation to promote 
readthrough, but it is unknown when this occurs during translation. The shift in stem 2 
may occur often, but may  promote readthrough at a particular angle, or only in concert 
with other events.  It is also unknown how long the pseudoknot stays in a readthrough 
promoting conformation; presumably  this occurs in a matter of seconds. Therefore it  was 
necessary  to design a protocol that would allow us to prepare a sample with a high 
proportion of ribosomes ‘caught’ in the act of allowing readthrough (Figure A -9). 
The first parameter we attempted to adjust was the amount of readthrough. Since we 
aimed to explore how readthrough occurs in wildtype MoMLV we opted not to use 
hyperactive pseudoknot mutants. Instead, assuming that  readthrough and termination are 
exclusive, we attempted to reduce termination. We used commercially prepared rabbit 






arrest translation at PK
(no readthrough or termination) and 
isolate occupied ribosomes
induce ‘readthrough’ conformation








• New mRNA that lacks Glu codons up 
to PK.
• Reduce glutamine from reaction mix 
(dialysis).
• Reduce eRF1 via IP to reduce 
termination if necessary
• Reduce tRNA from mix (?)
• Centrifuge sample to separate 
ribosomes from translation mix
• Use PP7 hairpin to pull out 
ribosomes with experimental 
construct (termination should 
release mRNA)
• RnaseH cleavage to separate 
ribosomes from beads
• Return ribosomes to translation 
mix treated with micrococcal 
nuclease (or tRNA depleted).
• Add excess of tRNAglu and 
GDPNNP; pull out ribosomes with 
hairpin (any terminated transcripts 
shouldn’t be attached to 
ribosomes).
• Freeze sample for Cryo-EM
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Figure A-9. Proposed experimental design for cryo-EM structure of MoMLV 
pseudoknot promoting readthrough on the ribosome.  
the lysate by conjugating Sigma and Abcam antibodies to eRF1 to IgA beads and 
incubating IVT lysates overnight at 4°C. We recovered the lysate and added the 13PK6 
reporter pair mRNAs. We saw a drastic increase in readthrough with eRF1 depletion 
(Figure A-10). We also probed the immuno-depleted lysates for eRF1 and saw a 
reduction in eRF1 levels. Thus, it appears that we can increase the population of 
readthrough ribosomes via eRF1 depletion. We tested the HIV-1 reporter pair in eRF1 
depleted IVT lysate as well as a negative control, believing that we would see no change 
in frameshift. However, we observed that eRF1 depletion also increased frameshift 
efficiency. This result  was corroborated by work from Doughterty  et  al. (Kobayashi, 
Zhuang et al. 2010) as described in Chapter 2, defining a role for eRF1 as a modulator of 
frameshift.
To freeze ribosomes in the act of readthrough of the UAG stop codon, it is necessary to 
stall the ribosomes at the UAG stop codon. Ideally, we would visualize the tRNAgln in the 
A site in conjunction with the UAG stop codon to examine the mechanism by which the 
near-cognate amino acid in accepted. Replacement of GTP with a non-hydrolyzable 
analog, GDPNP allows tRNA to load into the A site, but does not allow translocation, 
thereby stalling translation. This method is widely used to visualize tRNAs in prokaryotic 
ribosome structures; yet, it is nonspecific and will affect translation at any  codon. We 
designed an mRNA that  did not contain glutamine codons upstream of the stop codon to 
allow translation of the mRNA to the stop codon in the absence of tRNAgln, thereby 



























Figure A-10. Effects of eRF1 depletion on recoding in IVT lysate. A. Readthrough 
percentages based on dual luciferase assay results of the 13PK6 and HIV-1 reporter 
pairs translated in in-vitro lysates depleted of eRF1. Error bars correspond to standard 
deviation of averages derived from triplicate readings of each reaction. 
continue past the UAG codon to the downstream sequence. In the absence of termination, 
we anticipated there would be a stalling of the ribosome at the stop codon. We would then 
purify the ribosomes with the reporter mRNA by  the PP7 hairpin purification method 
(Hogg and Collins 2007) and add them to a buffer containing only  charged tRNAgln and 
GDPNP. Since the incorporation possible in this environment would be that  of tRNAgln at 
the stop codon we hoped to freeze enough ribosomes in the act of incorporating 
glutamine at the stop codon to visualize by cryo-EM.
To complete the experimental system the tRNA population of the IVT mix must be 
controlled. We discovered a method published by Jackson, Brierley et al. (Jackson, 
Napthine et al. 2001) that effectively depletes IVT lysates of tRNAs using an 
ethanolomine blocked epoxy-sepharose column. We performed this method on the IVT 
lysates, and translated the 13PK6-C dual luciferase plasmid.  Translation was reduced by 
~ 85% in treated lysates and was rescued to normal levels with the addition of exogenous 
calf-liver tRNA (Figure A-11). Thus we show that  we are able to clear the IVT lysates of 
the majority of existing tRNAs which is the first step in customizing the tRNA population 
of the IVT lysate.
Separation of tRNAs has been accomplished by column chromatography, but is labor 
intensive and would require considerable optimization in our lab.  De-acylation of tRNAs 































































































Figure A-11. Translation in tRNA depleted IVT lysates. A. Readthrough percentages 
based on dual luciferase assay results of the 13PK6 reporter pair transcribed and 
translated in in-vitro lysates depleted of tRNAs. Error bars correspond to standard 
deviation of averages derived from triplicate readings of each reaction. 
recharged in appropriate buffers (Pestova and Hellen 2005). We initially  believed we 
could construct a short pseudoknot containing mRNA that contained methionine and 
lysine codons up  to the UAG stop  codon. Commercially  available fluorescent labeled 
tRNAlys would allow visualization of the mRNA and a readout of termination and 
readthrough products based on size. Initiation and elongation to the point  of readthrough 
could be accomplished in the commercial IVT depleted of eRF1, and tRNAgln would be 
added in a reconstituted translation mix after ribosome purification. Glutaminyl 
synthetase was produced in bacteria and purified to use to charge tRNAgln in an in-vitro 
reaction. However, we would also need to produce eEF1 as a chaperone.  eEF1 exists as a 
trimer and is extremely labile; it has been purified by Pestova et al. ((Kolupaeva, de 
Breyne et al. 2007) ), but it is unclear that producing the subunits in bacteria and 
combining them would yield a functional protein. In addition, we were unable to see 
translation of the experimental construct. We theorized that was a result of the high 
number of lysine residues or the small size of the product. 
We redesigned our mRNA CEMPK (Figure A-12) to include 6 kb of MoMLV gag 
upstream of the stop codon, altering wildtype glutamine codons so no gluatmine would 
be incorporated before the stop codon. We hypothesized that by customizing the amino 
acid pool in the IVT lysate we could control charging of de-acylated tRNAs. We dialyzed 
the transcription and translation (TnT) IVT lysate against Buffer E supplemented with 
GTP (Kolupaeva, Pestova et al. 1998; Kolupaeva, Pestova et  al. 2000; Kolupaeva, de 
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Figure A-12. MoMLV pseudoknot constructs for cryo-EM structure.             
(A) Schematic of an initial construct for cryo-EM structure of the MoMLV 
pseudoknot on the ribosome. A short spacer of methionine and lysine residues is 
placed before the UAG stop codon and pseudoknot sequence. ** indicates a double 
UAA stop codon. The 3’ end of the construct contains the PP7 phage coat 
interacting RNA sequence for purification, and and RNase H cleavage site to allow 
separation from beads after purification. (B) Schematic of revised construct for 
cryo-EM structure of the MoMLV pseudoknot on the ribosome. The construct 
contains a 3X N-terminal flag tag and native MoMLV gag sequence before the 
UAG stop codon and pseudoknot sequence encoding a 6 kD termination product. 
The CAG codons preceding the were changed to CAA. A section of the native 
MoMLV pol sequence is present after the pseudoknot, encoding a 9 kD 
readthrough product. ** indicates a double UAA stop codon. The 3’ end of the 
construct contains the PP7 phage coat interacting RNA sequence for purification, 






















b: TnT lysate (+ buffer E)
c: Dialyzed TnT Lysate
d: Dialyzed TnT Lysate + amino acid mix
e: Dialyzed, tRNA depleted TnT Lysate
f: Dialyzed, tRNA depleted TnT Lysate + amino acid
g: Dialyzed, tRNA depleted TnT Lysate + amino acid + tRNA
Figure A-13. Figure A-13: Translation in dialyzed TnT IVT lysate. Readthrough 
percentages based on dual luciferase assay results of the 13PK6 reporter pair transcribed 
and translated in in-vitro lysates dialyzed to deplete amino acids and/or depleted of 
tRNAs. Error bars correspond to standard deviation of averages derived from triplicate 
readings of each reaction.  
cDNA to a TnT reaction with and without addition of amino acids and tRNAs and 
measured translation as rluc signal. There was a radical reduction in translation in 
dialyzed lysates that  was rescued by the addition of amino acids (Figure A-13). In lysates 
also depleted of tRNAs, the reduction in readthrough was even greater but the recovery 
was also reduced. This may have been an artifact of multiple freeze-thawing of the lysate 
in between steps that could be optimized. 
Concurrent to the dialysis experiments we attempted to visualize translation of the 
revised PK containing mRNA. We optimized our gel and transfer protocols to visualize 
small peptides, but we were unable to detect expression of either termination or 
readthrough products, with either Fluorotech tRNA or radioactive methionine 
incorporation. We added a flag-tag to the N terminus of the CEMPK construct, but we 
could still not detect the product, even after Flag-IP of IVT lysates.  It  is possible that the 
pseudoknot interferes with translation initiation of CEMPK or there is another aspect of 
the experimental construct that prevents translation in vivo.  We plan to continue work on 
an experimental construct for which we can verify translation of termination and 
readthrough products. Our attempts at customizing the IVT lysate will also provide 
further opportunities for studying recoding. 
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